Tom
Futai Lue
PRESENT TITLE:
Professor
July 1, 1992 to date
Department
of Urology
University
of California
San
Francisco, California 94143-0738
(415)
476-1611 FAX: (415) 476-8849
TLue@urol.ucsf.edu
Medical
director August
1, 1997 to date
Knuppe
Molecular Urology Laboratory
UCSF/MT.
Zion Medical Center
1600
Divisadero Street
San
Francisco, CA 94115
(415)
353-7205
Vice
Chair July
1, 1999 to date
Department
of Urology
University
of California
San
Francisco, California 94143-0738
(415)
476-1611 FAX: (415) 476-8849
Emil
Tanagho Endowed Chair in Clinical Urology
UCSF July
1, 2004 to date
EDUCATION: Kaohsiung
Medical College September
1965 - June 1972
Kaohsiung,
Taiwan
(Summa Cum Laude)
POSTGRADUATE
TRAINING:
Rotating
Internship: Veterans
General Hospital; Taipei, Taiwan
July 1, 1971 -
June 30, 1972
Surgery
Residency: Mackay
Memorial Hospital; Taipei, Taiwan
July 1, 1973 -
June 30, 1975
Surgery
Internship: Jewish
Hospital Medical Center; Brooklyn, NY
July 1, 1975 -
June 30, 1976
Surgery
Residency: Brookdale
Hospital Medical Center; Brooklyn, NY
July 1, 1976 -
June 30, 1978
Urology Residency State University
of New York, Downstate Medical Center
Brooklyn,
NY
July
1, 1978 - June 30-, 1981
Fellowship: University of
California, San Francisco
(Clinical/Research) Department of
Urology
July 1, 1981 -
June 30, 1982
POSITIONS
HELD AFTER COMPLETION OF POSTGRADUATE TRAINING:
Chief
of Urology, December
1,1996- June 30, 1999
UCSF/MT.
Zion Medical Center
Associate
Professor of Urology July 1, 1987-June
30 1992
Assistant
Professor of Urology July 1, 1983 - June 30 1987
Clinical
Instructor of Urology July 1, 1982 - June 30, 1983
Department of Urology, School of
Medicine
University of California, San
Francisco
MEMBERSHIP IN SCIENTIFIC SOCIETIES:
1983-now Northern
California Urological Society
1983-1999 American Medical
Association
1984-now Western Section,
American Urological Association
1984-now International
Board Member, Brazilian Society for Impotence Research
1985-now International
Society of Impotence Research
Urodynamic
Society
San Francisco
Medical Society
California
Medical Association
American
Urological Association
Fellow, American
College of Surgeons
l986-now California
Urological Association
Society for
Impotence Research(US)
1988-now Genitourinary
Reconstructive Surgeons
Society of Basic
Urologic Research
Asia Pacific
Society of Impotence Research (Honorary member)
1989- Societe
Internationale d'Urologie
1990- Urological
Research Society (International)
1992- Society of
Genitourinary Surgeons
1993- Western
Urological Forum
HONORS
AND AWARDS:
Taiwan Medical Association Honor Award, 1972
Most
Outstanding Surgical Intern Award, Jewish Hospital Medical Center;
Brooklyn, New York, 1976
Ferdinand
C. Valentine Fellowship, New York Academy of Medicine, 1981 - 1982
1st
Prize, Laboratory Research, "Hemodynamic of erection
and clinical implications."
American Urological Association, Las Vegas, NV, 1983
1st
Prize, Joseph F. McCarthy Essay Contest,
"Neuroanatomy of penile erection and iatrogenic impotence". Western Section, American Urological
Association, Vancouver, B.C., 1983
2nd
Prize, Round Table session, "Penile erection
test". Western Section,
American Urological Association, Reno NV, 1984
1st
Prize, Joseph F. McCarthy Essay Contest "Priapism - a
refined approach to diagnosis and treatment." Western Section American Urological Association, Seattle,
Washington, July 1986.
2nd
Prize, Jean-Francois Ginestie prize, Second International
Congress on Impotence Research, "The Mechanism of Penile
Erection." Prague,
Czechoslovakia, June 1986.
1st
Prize, Miley B. Wesson Essay Competition, "The
mechanism of venous occlusion during erection." (coauthor and principal investigator) Western Section,
American Urological Association Annual Meeting, Seattle, Washington, July 1986
.
1st
Prize, Peter-Bischoff Prize, "The effects of
cigarette smoking on erection."
(coauthor) West Germany 1986 .
Most
outstanding physician award, East Bay Chinese Physicians' Association ,1987
C.E.Alken
Prize,
C.E.Alken Prize Foundation, Munich,West Germany,l987
David
Culp Lecturer, University of Iowa, Iowa City, Iowa 1987
Walter
H. Theobold Lecturer of The Institute of Medicine of Chicago, Chicago, Illinois
1988
Gold
Cystoscope Award, American Urological Association, Boston, MA, 1988
First
prize, Clinical Research (Herbert Newman Prize), Third
International Congress on Impotence Research (coauthor and principal
investigator), Boston, MA. 1988
Bruce
Stewart Memorial Lecturer, American Fertility Society Annual Meeting, 1988
Donier's
Most Innovative Research Award, American Foundation of
Urological Diseases, Dallas, Tx, May 1989
Second
prize, Lapides Essay contest. (coauthor and principal
investigator), May 1992
First
prize, Urodynamic Society Essay Contest, (coauthor and
principal investigator), May 1992
Outstanding
Alumni Award, Kaohsiung Medical College, Taiwan, June 1992
1st
Prize, Jean-Francois Ginestie prize, Fifth International
Congress on Impotence Research, Milano, Italy, September, 1992. (coauthor and
principal investigator)
1st
Prize, Norwich Eaton/Miley Wesson Essay contest, Annual
Meeting ,Western Section AUA, Maui, Hawaii, Oct. 1992. (coauthor and principal
investigator)
1st
prize, Urodynamic Society Essay Contest, (coauthor and
principal investigator), San Antonio, Texas, May 1993
1st
prize, Joseph F. McCarthy Essay Contest, (coauthor and
principal investigator),Western Section American Urological Association, 1993.
1st
Prize, Canadian Urological Assocation Essay Contest,
(coauthor and principal investigator), 1993.
Grand
prize, Lapides Essay contest. (coauthor and principal
investigator), AUA annual meetingSan Francisco, CA, May, 1994
2nd
Prize, Video Urology Times' most outstanding videotape award, 1995
Grand
prize, Lapides Essay contest. (coauthor and principal
investigator), AUA annual meeting ,Las Vegas, NV, 1995
Listed
in "The Best Doctors in America" by Steven Naifeh & Greg White
Smith, Woodward-White Inc, Publisher. 1993.
Listed
in "The Best Doctors in
America" by American Health Magazine, March, 1996.
Outstanding
Physician Award, Chinese Hospital Oct, 1997
1st
Prize, Jean-Francois Ginestie prize, 8th International
Congress on Impotence Research, Amsterdam, The Netherlands, September, 1998.
(coauthor and principal investigator)
1st
prize, Joseph F. McCarthy Essay Contest, (coauthor and
principal investigator),Western Section American Urological Association,
Hawaii, 1998.
Second
prize, Lapides Essay contest. (coauthor and principal
investigator), AUA annual meeting , Atlanta, Georgia, May 2000.
Yamanouchi
prize, Best abstract, (coauthor and principal
investigator), AUA annual meeting, Atlanta, Georgia, May 2000
Wu
Chieh-Ping’ Prize, Chinese Association of Urology,
Beijing, China, Aug 2000
Weyrauch’s
Award, Western Urology Forum, Mar 2003
America’s
Top Doctor (on erectile dysfunction), Men’s Health Magazine April 2003
William
Smart teaching Award, Dept. of Urology, UCSF, May 2003
Outstanding
Achievement Award, Andrology Society of Taiwan, March 2004
State-of-the-art
Lecturer:
1. Annual
Meeting of the American Urological Association, N.Y., N.Y., May 1986.
2. Annual
Meeting of the Northeastern Section of the American Urological Association,
Toronto, Canada, September 1986.
3. Annual
Meeting of the New York Section of the American Urological Association, Laguna
Niguel, October 1986.
4. 10th
International Symposium, Ludwig Boltzmann Research Institute, Vienna, Austria,
February 1987.
5. Annual
Meeting of the Western Section, American Urological Association, Kona, Hawaii,
February 1987.
6. Annual
Meeting of the American Urological Association, Boston, MA, June, 1988.
7. Eleventh International Symposium, Ludwig Boltzmann Research
Institute, Vienna, Austria, February 1990.
8.
Kliniken der Stadt Wuppertal, Universitat
Düsseldorf, Wuppertal, West Germany, Feb 1990.
9. Biannual Meeting, International
Society of Impotence Research, Rio de Janeiro, Brazil,Sep,1990.
10. Annual Meeting of the American Urological Association, Las
Vegas, Nevada, Apr. 1995.
BOARD CERTIFICATION:
American Board of
Urology, February 1983
LICENSURE:
Pennsylvania,
036915, October 15, 1976
New York, 137188,
January 19, 1979
California,
A33382, January 19, 1979
DEA No. AL1319587
VISITING
PROFESSORSHIPS
1. State University of New
York, Downstate Medical Center, Brooklyn, NY. October 1983.
2. Cornell University, New York Hospital,
New York, NY. October 1983.
3. National Defense Medical
College, Tri-service General Hospital; Taipei, Taiwan. November 1984.
4. National Taiwan
University; Taipei, Taiwan.
November 1984.
5. Kaohsiung
Medical College, Kaohsiung, Taiwan.
November 1984.
6. University
of Iowa, Iowa City, IA May 1985.
7. University
of Texas at Dallas, Southwestern Medical School, Dallas, TX, October 1985.
8. University
of Minnesota, December 1985.
9. Staedtische
Kliniken Kassel, West Germany, March 1986.
10. State
University of New York, Upstate Health Science Center, Syracuse, New York,
September 1986.
11. Amsterdam
Academische University, November
26, 1986.
12. George
Washington University, Washington, D.C., December 1986.
13. Baylor
College of Medicine, Houston,
TX, March, l987.
14. Eastern
Virginia Medical College, Norfolk, Virginia, June l987
15. Albert
Einstein College of Medicine, Bronx, NY, September 1987
16. Harvard
Medical School, Brigham & Women's Hospital, November 1987
17. Johannes
Gutenberg University, Mainz, West Germany, December 1987
18. University
of Colorado, Denver, Colorado, January 1988
19. University
of British Columbia, B.C. Canada, April 1988
20. University
of Utah , Salt Lake City, Utah, November 1988
21. National
Cheng Kung University, Tainan, Taiwan, November 1988
22. University
of Cincinnati, Cincinnati, Ohio, March, 1989
23. Southern
Illinois University, Springfield, Ill. June, 1989
24. University
of Sao Paulo, Sao Paulo, Brazil, Aug. 1989
25. University
of Virginia, Charlottesville, Virginia, Sep. 1989
26. Universita
Cattolica Del Sacro Cuore, Rome, Italy, October, 1989
27. University
of Wisconsin, Milwaukee, WI, November, 1989
28. New
York University, NY, NY, December, 1989
29. Society
of University Urology Resident, May, 1990
30. University
of Buenos Aires, Argentina, September, 1990
31. University
of Kentucky (Edward H. Ray, Sr. visiting professor), September, 1990
32. University
of Louisville, Kentucky, September, 1990
33. Trippler
Medical Center, Hawaii, Oct. 1990
34. Queen's
University, Kingston, Canada, Sep. 1991
35. New
York Section, American Urological Assoc. Oct. 1991
36. St.
Vincent's Hospital, Sydney, Australia, Nov. 1991
37. Brigham
& Women's Hospital, Harvard Medical School Dec. 1991
38. Johns
Hopkins University, March, 1992
39. University
of California, San Diego, June 1992
39. University
of Miami, April, 1993
40. University
of Wisconsin, Madison, May, 1993
41. Cedars-Sinai
Medical Center (Adolph A. Kutzmann visiting professor), Nov. 1993
42. Chung-Gan Memorial Hospital, Taipei, Taiwan March, 1994
43. Loyola
University, Chicago, IL, Jan, 1995
44. University
of North Carolina, Chapel Hill, April, 1995
45. Alexander
& King Visiting professorship, University of Texas, Dallas, April, 1995
46. University
of Texas, San Antonio, TX. Mar. 1996
47. Wilford
Hall Hospital, San Antonio, TX. Mar. 1996.
48. Baylor
University, Houston, TX, Mar. 1996.
49. Rocky
Mountain Urologic Society, Denver, CO, Apr 1996
50. Edward
H. Ray, Sr. Visiting professor, University of Kentucky, Lexington, Kentucky,
Sep. 1996
51. University
of Louisville, Louisville, Kentucky, Sep. 1996
52. University
of Arizona, Tucson, AZ. May 1997
53. New
England Section AUA annual
meeting. Boston MA, Sep. 1997
54. North
Central Section AUA annual meeting, Monterey, CA, Sep. 1997
55. Confederation
of American Urology and Panamanian Urologic Society, Panama City, Panama, Jan
1998
56. Ohio
Urologic Society, Columbus, Ohio, Mar 1998
57. Suez Canal
University, Ismalia, Egypt, Sep 1998.
58.
University of Texas, Southwestern Medical School,
Dallas TX, May 1999
59.
Tripler Army Medical Center and Urologic Society of
Hawaii, Sep 1999
60.
Albany Medical College, Albany New York, May, 2000.
61.
Madigan Army Medical Center, Tacoma, WA, Oct, 2000.
62.
Long Island Jewish Hospital, New York, Feb 2001
63.
Los Angeles Urologic Society, Los Angeles, CA, Feb
2001
64.
Jamaican Urologic Society, Kingston Jamaica, Feb 2001
65.
University of Florida, Gainesville, Fl Apr 2001
66.
Erasmus University, Rotterdam, The Netherland, May
2001
67.
University of British Columbia, Vancouver, BC,
Canada. Feb. 2002
68.
University of Pennsylvania, Philadelphia, PA, Apr.
2002
69.
Loma Linda University, Loma Linda, CA Apr. 2002
70.
US Naval Hospital & San Diego Urologic Society,
San Diego, CA Aug 2002
71.
Peiking University Medical School, Beijing, China,
Sep 2002
72.
University of Colorado, Denver, CO, Apr 2003
73.
University of Oslo, Norway, Aug 2003
74.
Urologische Klinik und Poliklinik der Technischen
Universitat, Munich, Germany Oct 2003
75.
Boston University, Boston, MA Oct 2003
76.
University of Indiana, Indianapolis, IN. Apr 2004
INVITED LECTURES:
1. Guest speaker,
Reproductive Biology Seminar, Johns Hopkins University, Baltimore, MD. October 1983.
2. Invited speaker, New York
University, Cabrini Medical Center, New York, NY. October 1983.
3. Guest speaker, Kimbrough
Urological Seminar, San Francisco.
November 1983.
4. Invited speaker, Hospital
Pontchaillou, Rennes, France. June
1984.
5. Guest speaker XI Congress,
Brazilian Society of Human Reproduction, Sao Paulo, Brazil. September 1984.
6. Guest speaker, Pacific
Coast Fertility Society, 32nd Annual Meeting, Rancho Mirage, CA September 1984.
7. Guest speaker, MENSA,
Northern California Chapter.
September 1984.
8. Guest speaker, 77th Annual
meeting, Taiwan Medical
Association; Taipei, Taiwan.
November 1984.
9. Guest speaker, Chung-Gon
Memorial Hospital; Taipei, Taiwan.
November 1984.
10. Guest
speaker, National Defense Medical Center, Dept. of Physiology; Taipei,
Taiwan. November 1984.
11. Guest
speaker, National Taiwan University, combined Grand Rounds of Urology and
Rehabilitation Departments; Taipei, Taiwan. November 1984.
12. Invited
speaker, symposium of "Controversies in the Diagnosis and Treatment of
Impotence." Leiden, The
Netherlands. November/December
1984.
13. Guest
speaker, Second Stanford symposium on Evaluation and Treatment of Male Sexual
Dysfunction; Palo Alto, CA March 1985.
14. Invited
speaker, biomedical engineering forum, American Urological Association Annual
meeting; Atlanta, GA May 1985.
15. Invited
speaker, postgraduate course - Urologic Prosthetic Devices: Impotence, Incontinence. American Urological Association Annual
Meeting; Atlanta, GA May 1985.
16. Invited
speaker, Memorial Hospital, Savannah, GA
May 1985.
17. Invited
speaker, Mt. Zion Hospital, San Francisco, CA June 1985.
18. Guest
speaker, Seattle Urological Society, Seattle, WA July 1985.
19. Guest
speaker, International Combined Meeting of the Sleep Research Society and
Association of Sleep Disorders Centers, Seattle, WA July 1985.
20. Invited
speaker, Combined Urology and Radiology and Radiology Meeting, Harbor View
Medical Center, Seattle, WA, July 1985.
21. Invited
speaker, Diabetic Clinic, UCSF, San Francisco, CA 1985.
22. Invited
speaker, UCLA San Fernando Valley Program, October 1985.
23. Invited
speaker, Nephrology Grand Rounds, UCSF, San Francisco, CA 1985.
24. Guest
Speaker, Urology Grand Rounds, Stanford University, January 25, 1986.
25. Guest
Speaker: 5th International
Symposium of Operative Andrology, Berlin, West Germany. March 14-15, 1986.
Also
served as moderator for the first session on physiology.
26. Faculty
in Department of Radiology postgraduate course "Advances in
Uroradiology," UCSF.
27. Guest
Speaker, postgraduate course of the American Society of Andrology, Grand
Rapids, Michigan, April 20, 1986.
28. Guest
speaker, Kaiser Southern California Urology Group, Los Angeles, CA May 2, 1987.
29. Conference
on male sexual dysfunction, sponsored by NIDDKS, NIH, Baltimore, Maryland, June
5-6, 1986.
Chairman
of Section I: Physiology of
erection.
30. Guest
faculty member, Postgraduate course, Department of Urology, Northwestern
University, Chicago, Illinois, June 7, 1986.
31. Guest
speaker, Department of Urology and Physiology combined meeting, University of
Copenhagen, Denmark, June 11, 1986.
32. Guest
speaker, Pre-Congress teaching, Second World Congress on Impotence, Prague,
Czechoslovakia, June 16, 1986.
33. Guest
faculty member, Postgraduate
course, Department of Medicine, UCSF, June 25, 1986.
34. Guest
speaker, Urological Grand Rounds, Children's Hospital, San Francisco, September
8, 1986.
35. Faculty
member, American Urological Association postgraduate course on impotence, San
Diego, September 12-13, 1986.
36. Guest
faculty member, UCSF Postgraduate Course on Endocrinology, October 18, 1986,
37. Guest
faculty member, UC San Diego Postgraduate Course on Impotence, San Diego, Ca,
November 14-15, 1986.
38. Faculty
member, New York University Postgraduate Course, December 5-6, 1986.
39. Urology
Council Lecturer, National Kidney Foundation Annual Meeting, Washington, D.C.,
December 7, 1986.
40. American
College of Physicians and Geriatric Medicine, UCLA, Santa Monica, CA January
1987.
41. Invited
speaker, UCLA School of Medicine, postgraduate course on sexual science, "Bridging the disciplines with the
master clinician, Santa Monica, CA, February 1987.
42. Guest
speaker ,Houston Urological Society , Houston, TX, March, l987.
43. Guest
speaker, Orange County Urological Society, Orange County, CA. March, l987
44. Guest
faculty member, Stanford
postgraduate course, Stanford, CA. April, l987
45. Faculty member, American Urological
Association, postgraduate course, Toronto, Canada, April,l987.
46. Guest
speaker, Los Angeles County Urologic Society, Los Angeles, CA, April l987.
47. Guest
speaker, American Association of sex educators, counselors and therapists,
New York, NY, April l987.
48. Guest
speaker, Valley Presbyterian Hospital, Van Nuys, CA, May l987.
49. Guest
speaker, Urological Society of Belgium, Brussels, Belgium. June l987
50. Guest
speaker, 5th Forum of International Andrology, Paris, France, July l987
51. Invited
speaker, St. Gallen Hospital, St. Gallen, Switzerland, July l987
52. Guest
speaker, Community Hospital of Santa Cruz, Santa Cruz, CA, August l987
53. Guest
speaker, Master Conference for Urology by Merck Sharp & Dohme, Monterey,
CA, August l987
54. Guest
speaker, Master Conference for Urology by Merck Sharp & Domhe, Absecon NJ,
August 1987
55. Guest
speaker, Master Conference for Urology by Merck Sharp & Domhe, New Port
Beach, CA, September l987
56. Guest
speaker, John Muir Hospital, Walnut Creek, CA, September 1987
57. Guest
speaker, New York Academy of Medicine, September 1987
58. Co-chairman,
Annual Advanced Seminar in Urologic Surgery, UCSF, San Francisco, CA, October
1987
59. Guest
faculty, Urology postgraduate conference, University of Iowa, Iowa City, Iowa,
October 1987
3rd
Annual David A. Culp Lecture:
Pharmacologic tools in the diagnosis and treatment of impotence
60. Invited
speaker, Annual Clinical Assembly of Osteopathic Specialists. Honolulu, Hawaii,
October 1987
61. Guest
faculty, UCSD postgraduate course, "Progress in impotence" San Diego,
CA, November 1987
62. Invited
speaker, Worcester Urologic Society, Worcester, MA, November 1987
63. Invited
speaker, Alken Prize Winner's annual meeting, Munich, West Germany, December
1987
64. Faculty,
AUA videoconference, Chicago, Illinois, December 1987
Video-presentations
65. Guest
speaker, Symposium Medicus, Alcapulco, Mexico, December 1987
66. Invited
speaker, Rocky Mountain Urological Society, Denver, Colorado, January 1988
67. Faculty
member, AUA postgraduate course on Urologic ultrasound, Houston , TX, January
1988
68. Fourth
Walter H. Theobold Memorial lecturer of the Institute of Medicine of Chicago
and the Chicago Urological Society. Chicago, Illinois, March 1988
69. Invited
faculty, Urology section, California Medical Association Meeting, Reno, NV,
March 1988
70. Faculty,
Advances in Endocrinology and Metabolism, UCSF post graduate course,
San Francisco, CA, March 1988
71. Faculty,
UCSF postgraduate course :controversies in uroradiology, San Francisco,
CA, March 1988
72. Invited
speaker, Workshop on "Practical Ultrasonography in Urology" Academic
Medical Center, Amsterdam, Netherlands, March 1988
Video-presentation: Pulsed
Doppler ultrasonography in the management of impotence
73. Invited
speaker, Mills-Peninsula Hospital, Burlingame, CA, April 1988
74. Guest
speaker , British Columbia Urological Association Annual Meeting, Vancouver,
B.C. Canada, April 1988
75. Guest
speaker, Second International symposium on Andrology, Centro De Urologia,
Andrologia y Sexologia de Baleares, Palma de Mallorca, Spain, May 1988
76. Guest
speaker, Northern California Angiology Society Meeting, Redwood City, CA,
May 1988
77. Faculty
member, American Urological Association postgraduate course on impotence and
infertility. Orlando, FL, June
1988
78. Invited
faculty member, Clinician's Workshop on Urodynamics and Impotence, Life-Tech,
Inc. San Francisco, CA, August 1988
79. Invited
speaker, Humana Hospital, San Leandro, San Leandro, CA, August 1988
80. Invited
speaker, Urology Faculty Meeting, Merck Sharp & Dohme, San Francisco, CA,
August 1988
81. Invited
speaker, San Francisco Surgical Society, San Francisco, CA, September 1988
82. Faculty,
Precongress Teaching, Third World Congress on Impotence Research, Boston,Mass.
October 1988
83. Invited
speaker, Surgery grand round, Stanford University, Stanford, CA, October 1988
84. Guest
speaker, Utah Urologic Society, Salt Lake City, Utah, November 1988
85. Guest
speaker, Taiwan Urologic Association, Taipei, Taiwan, November 1988
86. Guest
speaker, Veterans General Hospital, Taichung, Taiwan, November 1988
87. Guest
speaker, Surgical grand Round, Chung-Gung Memorial Hospital, Kaohsiung, Taiwan
November 1988
88. Guest
speaker, 20th Meeting of the Japanese Society of Impotence Research, Tokyo,
Japan, November 1988
89. Guest
speaker, Symposium on Male sexual Dysfunction, Singapore Urological
Association, Singapore, November 1988
90. Guest
speaker, Dept. of Plastic surgery, University of Singapore, November 1988
91. Faculty
member, Male Erectile Dysfunction Update Seminar, American Urological Association,
Acapulco, Mexico, January 1989
92. Guest
speaker, Eden Hospital, Castro Valley, CA, January 1989
93. Invited
speaker, Annual Meeting of the California Academy of Family Physicians, SF. CA.
Feb,1989.
94. Faculty
member, Vail Urology Conference, Vail, Colorado, Feb. 1989
95. Invited
speaker, 118th Annual Meeting of the California Medical Association and Western
Scientific Assembly, Anaheim, CA, March,1989
96. Invited
speaker, Cincinnati Urologic Society, Cincinnati, Ohio, March, 1989
97. Invited
speaker, Dermatologic grand round, Dept. of Dermatology, UCSF, March, 1989
98. Invited
speaker, Plastic surgery grand round, Division of Plastic Surgery, UCSF, April,
1989
99. Invited
speaker, Annual Meeting, American Academy of Physicians, SF,CA, April, 1989
100. Invited
speaker, American Society of Andrology, New Orleans, LA, April, 1989
101. Faculty,
American Urological Association postgraduate course, Dallas, TX, May,1989
102. Panelist,
Panel on impotence, Annual Meeting of the American Urological Assoc. Dallas,
TX, May '89
103. Invited
speaker, Kaiser Hospital, South San Francisco, May, 1989
104. Invited
speaker, Kaiser Hospital, Redwood City, May, 1989
105. Faculty,
Master conference: Urologists, sponsored by Miles Inc. Carlsbad, CA, June 1989
106. Invited
speaker, MSD Education program, Palo Alto, CA, June 1989
107. Invited speaker,
First International Symposium on Andrology, Sponsored by the University of Sao
Paulo, Sao Paulo, Brazil, Aug. 1989
108. Invited
Speaker, MSD Education program, Newport Beach, CA., Sep. 1989
109. Invited
speaker, Evangelismos Hospital, Athens, Greece, October, 1989
110. Invited
speaker, University of Copenhagen and Herlev Hospital, Copenhagen, Denmark
111. Invited
lecturer, 2nd Meeting of the Asia-Pacific Society of Impotence Research, Seoul,
South Korea, November, 1989
112. Invited
speaker, 82nd Annual Meeting of the Taiwan Medical Association, Taipei, Taiwan,
November, 1989
113. Invited
speaker, Kaohsiung Medical College, Kaohsiung, Taiwan, November, 1989
114. Invited
speaker, Medical grand round, Holy Cross Hospital, Chicago, Ill. Nov. 1989
115. Invited
speaker, Milwaukee Academy of Medicine, Milwaukee, WI, Nov. 1989
116. Invited
speaker, NYU postgraduate course" Update in Urological Surgery", NYC,
Dec. 1989
117. Invited
speaker, Portland Academy of Medicine and St. Vincent Hospital, Portland, OR,
and Eugene, OR, Dec. 1989
118. Education Leaders Work Shop, American Urological Association,
Houston, TX, Jan. 1990
119. Invited
speaker, UCLA urology postgraduate course, Los Angeles, CA Jan, 1990
120. Invited
speaker, University of Miami postgraduate course, Miami, Florida, Feb. 1990
121. Guest
Speaker: 9th International
Symposium of Operative Andrology, Berlin, West Germany. March , 1990.
122. Chairman,
AUA postgraduate course, Annual AUA Meeting, New Orleans, LA, May, 1990
123. Invited
speaker, European Urological Association, Postgraduate course, Amsterdam, The
Netherlands, June, 1990
124. Guest
speaker, 45th Annual Meeting, Canadian Urological Association, Vancouver, BC,
June 1990
125. Guest
speaker, Kentucky Medical Association, Louisville, Kentucky, September, 1990
126. Invited faculty,
Western Section, AUA postgraduate course, Monterey CA ,Oct.1990.
127. Guest speaker: Hawaii
Urological society, Oct. 1990
128. Guest speaker,
Endocrine Society PG course, Hawaii, Oct. 1990
129. Guest speaker, Conference on
Reproductive issues and the aging
male, NICHD, Bethesda, MD; Nov.1990.
Chairman , session on "changes in erectile function with aging"
130. Invited faculty, AUA
postgraduate course, Washington DC, Dec.1990.
131. Invited faculty,
American Fertility Society PG course, Scottsdale AZ. Feb.7-9,1991
132. Invited speaker,
Endocrine grand round, UCSF, Feb 20,1991
133. Invited faculty, human
sexuality lectures to 2nd yr. medical student, UCSF, Feb 22,1991
134. Invited faculty,
California Medical Association, PG course, Reno, NV, March 10
135. Invited speaker, NIH
meeting on reproduction and physical disability, Washington, DC.
Mar.25-28,
1991
136. Invited faculty, Northwestern University PG Course,
Chicago, IL, Apr.19-20, 1991.
137. Invited speaker, Alta
Bates Hospital, Berkeley, CA, May,1991
138. Chairman, AUA
postgraduate course on impotence, Toronto, Canada, June,1991
139. Invited faculty,
Medical College of South Carolina, Charleston SC, June,1991
140. Invited speaker,
Stanford University, Stanford, CA, June, 1991
141. Invited speaker, 3rd
Biennial meeting, Asia Pacific Society
of Impotence Research, Taipei, Taiwan,
Nov. 1991
142. Invited speaker, St.
Vincent Hospital Seminar, Sydney, Australia, Nov. 1991
143. Invited speaker,
International Symposium of Operative Andrology, Istanbul, Turkey, Mar. 1992
144. Invited speaker,
Reproductive Biology Seminar, Johns Hopkins University, Baltimore, MD. Mar. 1992.
145. Chairman, AUA
postgraduate course on impotence, Washington DC, May, 1992
146. Invited faculty, AUA
postgraduate course, Houston, Texas, July 1992
147. Invited speaker, NIH
consensus meeting on sexual dysfunction, Bethesda, MD, Dec 7-9,1992
148. Invited faculty, University of
Florida PG course, Gainesville, Fl. Mar
5-7 , 1993
149. Invited speaker,
International conference on Peyronie's disease, Bethesda, MD, Mar 17-19, 1993
150. Invited speaker, Texas
Urological society meeting, Houston, TX, Apr 1-2, 1993
151. Invited faculty,
American Fertility Society PG course, Ft Lauderdale, Fl Apr 8-10, 1993
152. Invited speaker, Second
Annual Meeting, American Association of Clinical Endocrinologists, SF, CA May
13, 1993
153. Invited speaker, Urodynamic
Society Annual Meeting, San Antonio Texas, May 15, 1993
154. Chairman, AUA
postgraduate course on impotence, San Antonio Texas, May 19, 1993
155. Invited speaker, PG course,
Columbia-Presbyterian Medical Center, NYC, June 25, 1993
156. Invited faculty, AUA PG
course, Phoenix, AZ, Sep 10-12, 1993
157. Faculty, UCSF PG
course, SF, CA Oct1-2, 1993
158. Program Chairman and
faculty speaker, GURS annual meeting, SF CA, Oct. 12, 1993
159. Moderator, Urology
panel discussion, ACS annual meeting, SF CA, Oct. 13, 1993
160. Chairman, Surgical
Forum (Urology), ACS annual meeting SF CA Oct. 14, 1993
161. Invited speaker, Curso de
urologia para postgraduados, Madrid Spain, Oct 25-27, 1993
162. Invited speaker, Hong Kong
Urological Association, Hong Kong, March 10, 1994
163. Invited speaker, seminar on impotence,
Seoul, Korea. March 12,1994
164. Invited speaker, Taiwan
Urological Association, Taipei, Taiwan, March 14, 1994
165. Invited speaker, The Confederation
Americana De Urologia, San Francisco, CA. May 14, 1994
166. Invited speaker, Society for the study of
impotence meeting, San Francisco, CA. May 14, 1994
167. Invited speaker, AUA evening seminar, San
Francisco, CA. May 14, 1994
168. Chairman, AUA postgraduate course ,
San Francisco, CA. May 18, 1994
169. Invited speaker,
Canadian Urol Association Annual Meeting,
June 27-30, Jasper Alberta, Canada
170.
Invited speaker, Chinese
American Med. Society Annual Meeting, NYC, July 1-3, 1994
171. Invited speaker,
Endocrine PG course, University of Oregon, Aug 6, 1994
172. Invited speaker,
Florida Urol Society meeting , Miami, Sep 30, 1994
173.
Invited speaker, Uroradiology
conference, SF, CA, Oct 2, 1994
174. Invited speaker, St.
Helena Hospital, St Helena, CA Oct 27, 1994
175. Invited speaker, French
Urological Society Annual Meeting, Paris, France, Nov , 1994
176. Invited speaker,
International symposium on basic and clinical pharmacology of penile smooth muscle, Madrid,
Spain, Dec, 1994
177. Invited faculty, AUA PG
course, Washington DC. Dec, 1994
178. Invited speaker, Summit
Hospita, Okland, CA, Jan 1995
179.
Chairman, PG course on
impotence and Peyronie's disease, AUA Las Vegas, NV, Apr. 1995
180. Invited speaker,
Montreal ,Quebec Urol Assoc Annual meeting, Quebec, Canada, May, 1995
181. Invited speaker,
Northern Cal chapter , ACS annual meeting , SF, CA, May, 1995
182. Invited speaker,
International Andrology meeting, Istanbul, Turkey, May, 1995
183. Invited speaker,
Southern California, Kaiser group meeting, LA, May, 1995
184. Invited faculty, AUA PG
course, Orlando Fl. June,1995
185. Co-chairman, UCSF PG
course 'Update on urinary
incontinence' SF, CA, July, 1995
186. Invited speaker, University
of Massachusetts PG course on impotence, July, 1995
187. Invited faculty,
McDonald Urologic Seminar, Scottsdale, AZ, Mar, 1996
188. Invited speaker, Columbia
University PG seminar on
impotence, LA CA, Mar 1996
189.
Chairman, PG course on
impotence and Peyronie's disease, AUA Orlando, FL, May. 1996
190. Invited faculty, Video conference
on erectile dysfunction. St. Louis, MO, May 1996
191. Invited faculty,
American College of Cardiology seminar, WY Aug, 1996
192. Invited Keynote speaker, Society of
Phalloplasty Surgeons, Aspen, CO, Oct, 1996
193. Chairman, International
Society of Impotence Research Biannual meeting SF, CA Nov 1996
194. Invited faculty, American College
of Surgeons Annual Meeting, PG course " Urological Surgery: Advances
in Urological Imaging",
SF,CA., Oct. 1996.
195. Invited speaker, American
College of Surgeons Annual meeting. Panel discussion on erectile dysfunction.
SF, CA., Oct, 1996
196. Invited faculty,
Postgraduate seminar, Western section, AUA. LA CA, May 1997
197. Invited faculty,
Postgraduate seminar, SUNY Health Science Center in Brooklyn, Brooklyn NY,
May
1997
198. Invited speaker, Endocrine Society Meeting, Minneapolis, MN, June, 1997
199. Invited faculty, 2nd
International symposium on erectile dysfunction, Columbia University, LA, CA
Sep
1997
200. Invited faculty,
Postgraduate seminar, University of Texas Southwestern, Dallas, TX
Oct
1997
201. Invited speaker, Sequoia
Hospital, Redwood City, CA Oct. 1997
202. Invited speaker,
Biannual meeting, Asia Pacific Impotence Society Meeting, Kula Lumpur,
Malaysia, Oct,
1997
203. Invited speaker,
Brazilian Urologic Society annual meeting, Blumenal, Brazil, Oct 1997
204. Invited speaker,
Kimbrough Urology Seminar, San Francisco, CA, Oct 1997
205. Invited speaker, Kaiser
Hospital, Oakland, CA Oct 1997
206. Chairman, AUA PG course
"Erectile dysfunction, priapism and Peyronie's disease" Washington
DC, Dec 1997
207. Invited speaker, NIH
urinary incontinence meeting, Jan 1998
208. Invited speaker, Pacific Interurban Clinical Club, Feb
1998
209. Invited speaker, Andrology Society of Taiwan, Mar 1998
210. Invited speaker, First International Congress on Penile
Diseases, Florence, Italy, Mar 1998
211. Invited speaker, Second Arctic Urologic Society meeting, Mar 1998
212. Invited speaker,
Department of Obs/Gyn research seminar, UCSF, May 1998
213. Co-Chairman in urology:
Northern Cal ACS meeting May 1998
214.
Invited speaker, Urodynamic
Society meeting, San Diego, CA May 1998
215. Invited speaker,
Confederation of American Urology meeting, San Diego, CA May 1998
216. Invited Panelist on
impotence diagnosis, AUA annual meeting, San Diego, CA May 1998
217. Chairman, AUA PG course
" Impotence, Peyronie's disease and priapism", San Diego, CA May 1998
218. Invited speaker, Brown
Bag lectures, UCSF, July, 1998
219. Invited speaker,
Nephrology and primary care ground round, UCSF, August, 1998
220. Invited faculty,
International Congress of Impotence Research Meeting, Amsterdam, August, 1998.
221. Invited speaker,
Chinese Urologic Society Meeting, Shanghai, China, September, 1998.
222. Invited speaker, Asian
Urologic Society Meeting, Singapore, September, 1998.
223. Invited faculty, 3rd
International symposium on erectile dysfunction, LA, CA, October, 1998
224. Invited faculty,
American College of Surgeons Annual Meeting, SF, CA, Oct 1998
225. Co-chair and speaker,
NIH Science Writers' conference, Bethesda MD, Oct 1998
226. Faculty, UCSF Urology
PG course, SF CA Dec 1998
227. Invited faculty,
CAPSURE meeting, Cabo, Mexico, Feb 1999
228. Invited faculty, AUA
Annual Review Course, Houston, TX, Mar 1999
229. Invited faculty, UCSF
Endocrine PG course, SF CA, Mar 1999
230. Invited faculty,
International Andrology Meeting, Buenos Aires, Argentina, Mar 1999
231. Invited speaker,
International Andrology Meeting, Buenos Aires, Argentina, Mar 1999
232. Invited speaker, Society
for the Study of Impotence Annual meeting, Dallas, TX, May 1999
233. Chairman, AUA annual
meeting PG course "Erectile dysfunction, priapism and Peyronie's
disease" Dallas, TX, May 1999
234. Invited speaker, Taiwan
Medical Association Seminar, Kaohsiung, Taiwan June 1999
235. Invited speaker,
Scandinavian Urological Society Annual Meeting, Reykjavik, Iceland, June 1999
236. Invited speaker,
American Endocrine Society annual meeting, San Diego CA June 1999
237. Invited speaker,
Canndian Urological Society annual meeting , London, Ontario Canada June 1999
238. Invited faculty, 1st
International Consultation on Erectile Dysfunction, Paris, France July 1999
239. Invited speaker, Kaiser
Education Seminar, LA CA July 1999
240. Chairman, AUA
Postgraduate seminar "Erectile dysfunction, priapism and Peyronie's
disease" Vancouver, Canada August 1999
241.
Invited speaker, Society for the Study of Impotence
Seminar, Boston MA, Sep 1999
242.
Invited speaker, Pan Pacific Surgical Association
meeting, Honolulu, Hawaii,Jan 2000
243.
Invited speaker, Santa Teresa Community Hospital, San
Jose, CA Mar 2000
244.
Invited speaker, The Association of Andrology of
Republic of China, Taipei, Taiwan, March 2000
245.
Invited faculty, AUA Annual Review Course, Dallas,
TX, Mar 2000
246.
Invited faculty, Cleveland Clinic Postgraduate
course, Cleveland OH, Mar 2000
247.
Invited speaker, ACS, Northern Cal chapter, San
Francisco, CA May 2000
248.
Invited speaker, Fifth Asian Congress on Urology,
Beijing, China, Aug 2000
249.
Invited speaker, Autonomic Society Meeting, Puerto
Rico, Oct 2000
250.
Invited faculty, International Meeting on
Pharmacologic Treatment of Sexual Dysfunction, LA, CA Nov 2000
251.
Invited speaker, AUA Postgraduate seminar "Male
infertility and Erectile dysfunction, Washington DC, Dec 2000
252.
Invited speaker, Kimbrough’s Urology Meeting, San
Diego, CA Jan 2001
253.
Invited faculty, AUA Annual Review Course, Chicago,
IL, Mar 2001
254.
Invited faculty, University of South Florida, PG
course, Key West, Fl. Apr 2001
255.
Invited faculty, Acupuncture meeting, SF, CA Jun 2001
256.
Invited speaker, The Urological Association of the
Republic of China, Kaohsiung, Taiwan, Aug 2001
257.
Key note speaker, Biannual Meeting, Asian Pacific
Society of Impotence Research. Phuket, Tailand, Oct 2001
258.
Invited faculty, International Meeting on
Pharmacologic Treatment of Sexual Dysfunction, LA, CA Nov 2001
259.
Invited speaker, XVIII Congres de la Societe
d’Andrologie de Langue Francaise. Montpellier, France, Dec 2001
260.
Chairman, AUA Postgraduate seminar "Urologic
Management of Sexual Dysfunction" Puerto Vallarta, Mexico, Feb.2002
261.
Invited speaker, Annual Meeting of California Academy
of Family Physicians. San Francisco, CA. Feb. 2002.
262.
Invited faculty, AUA Annual Review Course, Chicago,
IL, Mar 2002
263.
Invited faculty, International meeting on erectile
dysfunction, Monte Carlo, France
264.
Endocrine grand round, UCSF May 2002
265.
Chairman, American Urological Assoc. PG course, Orlando FL May 2002
266.
Invited speaker, Spanish Urologic meeting at AUA,
Orlando FL, May 2002
267.
Invited speaker, Endocrine Society, SF CA May 2002
268.
Invited speaker, Chinese Urological Association,
Beijing, China, Sep. 2002
269.
Invited speaker, International Society of Impotence Research Congress, Montreal,
Canada, Sep. 2002
270.
Invited Speaker, Northeastern Section of AUA, Quebec,
Canada, Sep. 2002
271.
Invited Faculty, Urology Review Course, American
College of Surgeons, SF, CA Oct 2002
272.
Invited speaker, International College of Surgeons
Congress, Taipei, Taiwan Oct, 2002
273.
Chairman, Science Writers’ Conference on Sexual Medicine sponsored by American
Foundation of Urologic Diseases, NY, NY, Dec 2002.
274.
Invited Faculty, Sexual Medicine Society of North
America meeting, Boca Raton, FL, Jan 2003
275.
Chairman, AUA postgraduate course, Chicago, IL, May
2003
276.
Invited speaker, Endocrine Forum at AUA, Chicago, IL,
May 2003
277.
Invited faculty, AUA Annual Review Course, Chicago,
IL, May 2003
278.
Invited speaker, GYN grand round, UCSF June 2003
279.
Chairman, International Consultation on Sexual
Medicine, Paris, France Jul 2003
280.
Invited speaker, Radiation Oncology grand round,
UCSF, Sep 2003
281.
Invited speaker, Davies Med Center grand round, SF CA
Nov 2003
282.
Invited speaker, Urology grand round, Medical College
of Georgia, Augusta, GA Dec 2003
283.
Invited Faculty, Advances in Urology Course, Emory
University, Atlanta, GA Dec 2003
284.
Invited speaker, Bioengineering Society, San Francisco,
CA, May 2004
285.
Invited speaker, Spanish Urologic meeting at AUA, San
Francisco, CA, May 2004
286.
Co-Chair, AUA PG Course on ED, Peyronie’s disease and
priapism, San Francisco, CA, May 2004
287.
Invited faculty, Sexual Medicine Society of North
America, San Francisco, CA, May 2004
288.
Invited speaker, Andrology Society of Austria,
Salzburg, Austria Jun 2004
PRESENTATIONS:
1. Urology Grand Rounds. September 1982.
2. Society Internationale
d'Urologie. September 1982.
3. American Urological
Association, Las Vegas, NV. April
1983.
4. Urology Grand
Rounds. May 1983.
5. Western Section, AUA,
Vancouver, B.C. July 1983.
6. Health Education Program,
Chinese TV (Channel 48), San Francisco, July 1983.
7. PG course, Kaohsiung
Medical College Alumni Association, Los Angeles, CA. August 1983.
8. KQED Radio talk show, San
Francisco. August 1983.
9. KCRA TV, Sacramento,
CA. October 1983.
10. Grand
Rounds, Dept. of Family Practice,
SFGH. November 1983.
11. Canadian
Broadcasting Company (TV), Science Program. December 1983.
12. PG
course UCSF - Human Sexuality:
Issues for the Clinician.
April 1984.
13. American
Urological Association annual meeting, New Orleans, LA. May 1984.
14.
First World Congress on Impotence Research, Paris, France. June 1984.
15. Western
Section, American Urological Association, Reno, NV. July 1984.
16. Grand
Rounds, Kaiser Hospital, Oakland, CA.
August 1984.
17. Advances
in Urologic Oncology seminar PG course, UCSF. October 1984.
18. American
College of Surgeons 70th Annual Clinical Congress, San Francisco. CA. October 1984.
19. American
Urological Association annual meeting, Atlanta, GA. May 1985.
20. Western
Section, American Urological Association Meeting, Anaheim, CA. July 1985.
21. Co-chairman,
Annual Advanced Seminar in Urologic Surgery, "Update on Impotence and
Infertility", UCSF, San Francisco, CA, October 25-26, 1985.
22. Annual
National Meeting and Postgraduate course of the American Urological
Association, N.Y., N.Y., May 17-22, 1986.
23. Second
World Congress on Impotence Research, Prague, Czechoslovakia, June 17-20, 1986.
Chairman, Session 4: Examination of neural pathways.
24. Annual
Meeting of Western Section of American Urological Association, July 27-31,
1986.
25. Annual
Meeting of the Western Section of American Urological Association, February
22-27, 1987.
26. Annual
Meeting of the American Urological Association, May, l987
27. Annual
Meeting of the Western Section of AUA Meeting, Feb. 1988
28. Annual
Meeting of the American Urological Association June, 1988
29. Grand
round, Dept. of Urology, UCSF, June 1988
30. Postgraduate
Seminar, Urologic Oncology, Dept. Urology, UCSF, September 1988
31. Third
International Congress on Impotence Research, Boston, MA, October 1988
32.
Faculty member, Urology Postgraduate Seminar, Dept. Urology, UCSF ,Feb.
1989
Workshop: Duplex ultrasound evaluation of
penile arteries.
33. Grand
round, Dept. of Urology, UCSF, April, 1989
34.
Annual Meeting, American Urological Association, Dallas, TX, May 1989
Moderator of poster session 3
35. International
Urologic Seminar at UCSF, April, 1990
36. Annual
Meeting, American Urological Association, New Orleans, LA, May, 1990
Moderator, poster session on impotence
37. Annual
Meeting, American Urological Association, Toronto, Canada, June, 1991
Moderator, Podium section on impotence
38. Annual
Meeting, American Urological Association, Washington DC, May, 1992
Moderator, Podium section on impotence
39.
American Association of Genitourinary Surgeons meeting, Phoenix, AZ, April 15-18, 1993
41.
American Association of Genitourinary Surgeons meeting, Boca Raton, Fl, April, 1994
42.
Western Urological Forum, Napa, CA. March, 1994
43. Annual
Meeting, American Urological Association, San Francisco, CA. May, 1994
Moderator, Poster section on impotence
44.
Western Urological Forum, Puerto Vallarta, Mexico. March, 1995
45.
American Association of Genitourinary Surgeons meeting, Santa Fe, NM, April, 1995
46. Annual
Meeting, American Urological Association, Las Vegas, NV. April, 1995
47.
Western Urological Forum, Maui, Feb, 1996
48.
American Association of Genitourinary Surgeons meeting, Sea Island GA, April, 1996
49. Annual
Meeting, American Urological Association, Orlando, Fl April, 1996
50.
American Association of Genitourinary Surgeons meeting, La Quinta, CA, Mar 1997
51. Annual
Meeting, American Urological Association, New Orleans, LA. April, 1997
52. Western
Urological Forum, Sedona, AZ May 1997
53. Annual
Meeting, American Urological Association, San Diego, CA, June, 1998
54.
Annual Meeting, American Urological Association,
Dallas, TX. May, 1999
55.
American Association of Genitourinary Surgeons meeting, San Antonio, TX, April, 2000
56.
Western Urological Forum, Carmel, CA May 2000
57.
Annual Meeting, American Urological Association,
Atlanta, GA . May, 2000
58.
Western Urological Forum, Honolulu, HW Mar 2001
59.
American Association of Genitourinary Surgeons meeting, San Francisco, CA, April, 2001
60.
Annual Meeting, American Urological Association,
Anaheim, CA . Jun, 2001
61.
Western Urological Forum, Phoenix, AZ Mar 2002
62.
Prostate Cancer Retreat, Dept. of Urololgy, UCSF Mar.
2002
63.
American Association of Genitourinary Surgeons Meeting, Kiawah
Island, SC Apr. 2002
64.
Annual Meeting, American Urological Association,
Orlando FL, May 2002
65.
NIH Work Shop on pelvic floor dysfunction, Bethesda,
MD, Nov. 2002
66.
Western Urological Forum, Maui, HW Mar 2003
67.
American Association of Genitourinary Surgeons meeting, Tuscon, AZ, April, 2003
68.
Annual Meeting, American Urological Association,
Chicago, IL, May 2003
UNIVERSITY
SERVICE:
1. Chairman, ad hoc peer review committee ,
l987 ( Committee on Academic personnel)
2. Animal Research and Care Coordinator,
Department of Urology l988-now
3. Ad hoc academic review committee (Committee on Academic personnel), 1988,
89, 90, 94, 95
4. Radiation Safety Committee, Urology
representative, 1988
5. Animal User Committee, 1989
6. Committee on Admissions, School of Medicine 1989-1992
7. Committee on Equal
Opportunity, 1990-1993
8. Department
coordinator, 3rd year medical student teaching (Surgery 110), 1991-1993
9. Director of Research Laboratory,
Department of Urology, 1991-
10. Committee on Animal Research, 1992-1993
11. Member, physicians' professional standards board, VAMC,
1995-1997
12. Member, Surgical Committee, UCSF/Mt. Zion Hospital, 1997-
13. Member, Executive Medical Board, UCSF/Mt. Zion
Hospital, 1997-1999
14. Member, ad hoc peer review committee, (Committee on Academic
personnel), 1998, 200, 2002
15. Member, Quality improvement executive committee, UCSF/Mt. Zion
Hospital, 1998-
16. Member,
Operating room block time committee, UCSF/Mt. Zion Hospital, 1998-
17. Chair,
Urology faculty search committee, 2002, 2003
COMMUNITY
, PUBLIC AND GOVERNMENT SERVICES:
1. Lecture: "Urinary incontinence in the
elderly." Noe Valley Senior
Citizens Group, May 1983.
2. Lecture: "Urinary incontinence in the
elderly." Masonic-Ashbury
Senior Citizens Center, June 1983.
3. Lecture: "Diseases of the urinary
tract." Heritage Senior
Citizens Center, San Francisco, CA, April 1984.
4. Lecture: "Urinary incontinence." Francis of Assisi Senior Citizens
Center, San Francisco, CA, August 1984.
5. Lecture: "Kidney and urinary tract
diseases." Salvation Army,
San Francisco, CA, December 1984.
7. Medical consultant and
voluntary physician for South East Asian refugees: North East Medical Services. San Francisco, CA, 1981-1986.
8. Medical consultant: San Francisco Times (Chinese)
newspaper. San Francisco, CA,
1984-1985
9. Member , Ad hoc Committee for Impotence
Research--NIH, National
Institute
of Arthritis, Diabetes and Digestive and Kidney Disease. 1985
10. Member, American Urological Association Research
Think Tank, 1985
11. Member, Impotence Advisory Committee, American Urological
Association,1988-1984
12. Member, Special Study Section, NIH, Division of
Research Grant, 1989
13. Ad hoc reviewer, Veterans Administration Medical Research
grant, 1988,1989
14. Consultant, Program Committee, American Urological Assoc.
Annual Meeting, 1988-1989
15.
Member, Urology Council,
National Kidney Foundation, 1989
16.
Member, Program committee, American
Urological Association Annual Meeting, 1989-1998
17.
Member, Expert Advisory Panel on
Urology, the United States Pharmacopoeia Convention, Inc., 1990-1995
18. Ad hoc reviewer, Canadian Medical Research grant, 1990,1991
19. Ad hoc reviewer, Western Australian Medical Research grant,
1990,1991
20. Ad hoc reviewer, The Kidney Foundation of Canada,
1991
21. Member, membership committee. California Urological
Association, 1992-
22. Ad hoc reviewer, Drug Evaluations, AMA, 1992
23. Member, Initial Review Group, NIDDK, NIH,
7/92-6/96.
24. Co-chairman, Sexual Function Health Council,
American Foundation of Urological Diseases, 1994-
25. Member, Executive Committee, Society for the Study
of Impotence (USA) , 1994-1995
26. Chairman, Essay committee, Western Section AUA, 1994
27. Member, Video and Film Committee & Future
Meeting Planning Committee, International Society of Impotence Research, 1994
28. Executive committee member, International Society of Impotence
Research, 1994-1998
29. Program committee member, co-chairman urology
program, Northern California Chapter of ACS, 1995
30. Member, San Francisco-Shanghai Sister City
Committee, 1996-1998
31. Ad
Hoc Reviewer, VA Merit Review grant, 1997
32.
Vice president, National Erectile Dysfunction
Foundation, 1998-
33.
Member, Brown & Toland Commercial and Senior Wellness Advisory Council, 1998-
34.
Member, Trauma, Surgical and Musculoskeletal
Disorders Medical Research Group (MARG), Department of Vetrans Affairs,
2000-2001
35.
Member, AUA Practice Guidelines committee, ED, Guidelines
Panel, AUA, 5/2000-
36.
Member, AUA Complementary & Alternative Medicine
Committee, 5/2000-
37.
Northern California Cancer Center (NCCC) Patient
support group lecturer 2001, 2002
38.
Lecture to East/ West Bay Regional
Prostate Cancer Initiative Teams, American Cancer Society. 2004
39.
Team leader, Abstract review for AUA
annual meeting 2003, 2004
40.
Ad hoc Member, UKGD study section, NIDDK,
NIH, Jun 2004
POSTDOCTORAL
RESEARCH FELLOWS SUPERVISED:
Salim
J. Zeineh, M.D. (1982-83)
Shinn-Nan
Lin, M.D. (1983)
Regine
Brissot, M.D. (1983)
Assaad
Mounzer, M.D. (1983-84)
Drago
Milutinovic, M.D. (1983-84)
Klaus
Peter Juenemann, M.D. (1984-85)
Mohamed
Abozeid, M.D. (1984-85)
Yukie
Takimoto, M.D. (1984)
Jianan
Luo, M.D. (1984-85)
Stefan
Mueller, M.D. (1985-86)
J.T.
Hsieh, M.D. (1985-86)
Charlotta
Persson, M.D. (l986-87)
Sherif
R.G. Abo Seif, M.D. (1985-86)
Jan
Breza, M.D. (l986-87)
Francois
Benard, M.D. (l987-88)
J.H.L.Rudolph Bosch, M.D. (l987-88)
Wolfgang Diederichs, M.D. (l987-88)
Christian-Georg
Stief, M.D. (l987-88)
Andreas
Mersdorf, M.D. (1988-1989)
Yoshiatsu
Takahashi, M.D. (1988-1989)
Chii-Jye
Wang, M.D. (1988-1989)
Bernard
Marc, M.D. (1989-1990)
Jae-Seung
Paick, M.D. (1989-1990)
Markus
Hohenfellner, M.D. (1990-1991)
Flavio
E T Rocha, M.D. (1990-1991)
Craig
Donatucci, M.D. (1990-1991)
Luis
Martinez, M.D. (1991-1992)
Burkhard
von Heyden, M.D. (1991-1993)
Geng-Long
Hsu, M.D. (1991-1992)
Gerald
Brock, M.D. (1991-1993)
Serge
Carrier, M.D. (1992-1994)
Nam
Wee Kour, M.D. (1992-1993)
Shang-Sen
Lee, M.D. (1992-1993)
Michitaka
Yajima, M.D. (1992-1993)
Peter
Zvara, M.D. (1992-1993)
Katsuyuki
Baba, M.D. (1993-1994)
Michael
Probst, M.D. (1993-1995)
Hans
Piechota, M.D. (1994-1996)
Su-Tsung
Huang, M.D. (1995-1996)
Emre
Akkus, M.D. (1995-1996)
Gyung
Woo Jung (1995-1996)
Stefan
Dahms , M.D. (1995-1997)
Emre
Bakircioglu, M.D. (1996-1997)
Kenneth
Hsu, M.D. (1996-1997)
Ahmed
El-Sakka (1996-1998)
Maqsood
ul Hasan (1996-1997)
Karl-Dietrich
Sievert, M.D. (1997-1998)
Ming-Chan
Lee, M.D. (1998-1999)
Tulio
M. Graziottin, M.D.(1999-2000)
Julio
Resplande de Araujo Filho M.D. (1999-2000)
Hao
Chung Ho, M.D. (2000-2001)
Kuo
Chiang Chen, M.D. (2000-2001)
Amr
Jad, M.D. ((2000-2002)
Guiting
Lin, M.D., Ph.D. (2001-2004)
Pao-Shiu
Hsieh, M.D. (2001-2002)
Chung
hsin Yeh, M.D. (2001-2002)
GuiFang
Wang, M.D. (2001-2004)
Derek
Bochinski, M.D. (2002-2004)
Rafael
Ernesto Carrion, M.D. (2003-2004)
Narihiko
Hayashi, M.D. (2003-2005)
RESEARCH
RESIDENTS SUPERVISED:
Rodman
Rogers, M.D. (1999-2000)
Shahram
Gholami, M.D. (2000-2001)
Johnny
Chang, M.D. (2001-2002)
Donna
Deng, M.D. (2002-2003)
Nadeem
Rahman, M.D. (2003-2004)
RESEARCH
GRANTS:
Completed
1. Co-Investigator: Bladder Evacuation by Direct Sacral
Root Stimulation. Granted by NIH,
Bethesda, MD (#1-R01-NS-18029).
For period: April 1, 1982 -
March 31, 1985. Jacob K. Javits
Neurosciences Investigator Award:
April 1, 1985 - March 31, 1992.
2. Principal Investigator: "Medical Treatment for Erectile
Impotence." Granted by
Research Evaluation and Allocation Committee, UCSF. For period July 1, 1984 - June 30, 1985.
3. Co-Principal
Investigator: "Treatment and
Prevention of Impotence by Neurostimulation. " Granted by NIH, Bethesda,
MD (#-R01-HD19640). For
period: December 1, 1984 -
November 30, 1987.
4. Principal Investigator: " Treatment
and Prevention of Impotence by Neurostimulation." Granted by NIH , Bethesda , MD (# 2R01-HD19640).
April 1,1988-March 31,1991. (extended to 12/91)
5. Co-Principal investigator: Penile
erection device, Grant from Urosystems Inc. 1/90-12/93
6. Principal Investigator: "The effect
of vacuum constrction device on penile blood flow" grant from Osbon Inc.,
1990-1991
7. Principal Investigator: "
Prostaglandin E 1 on penile erection", a grant from Upjohn Company, 1991,
1992-1994
8. Principal investigator" The effect
of acupuncture on bladder function" Liteon Foundation.
9. Principal investigator:
" The effect of sertinole on ejaculatory function". a grant from
Abbott . 1993-1996.
10. Principal investigator: "Treatment and prevention of
impotence" Granted by NIH, NIDDKS (1 RO1 DK45370-01A2) August 1, 1994- -
July 31 1996.
11. Principal investigator: "Impotence", Veterans
Administration Merit Review Grant April 1, 1996-March 31, 1999.
12. Principal investigator: "Pathophysiology of stress
urinary incontinence" NIDDK, NIH, R55 DK 51374. 12/96-11/98.
13. Principal
investigator: "Stress urinary incontinence" Montgomery Street
Foundation. 1998-99
14. Principal investigator:
"Treatment and prevention of impotence" Granted by NIH, NIDDKS (2RO1
DK45370-03) Jan 1/ 98- 12/31/2001
15. Principal investigator: "Molecular mechanism
of female stress urinary incontinence" NIDDK, NIH, 2R01
DK 51374-02 ,
12/1/98-11/30/02
16. Principal
investigator, UCSF Prostate Cancer Center grant “The effect of growth factor
and cavernous nerve regeneration” 2000-2001
17. Principal
investigator Yamanoch grant. Relationship of prostatic enlargement and erectile
dysfunction. 2001-2002
18. Principal
investigator, UCSF prostate Cancer Center Grant “Stem cell and regeneration of
the cavernous nerve”2002-2003
Active grants:
1. Principal
investigator: "Treatment and prevention of impotence" Granted by
NIDDK, NIH
2RO1 DK45370-03, (1/1/04-12/31/08).
2. Co-PI,
Special Center of Research (SCOR) grant: 1 P50 DK64538-01 (PI:
Brown, Jeanette)
PI of project 2” Female stress incontinence:
molecular mechanism and matrix-based therapy” NIDDK, NIH, 9/30/02-8/31/07.
CLINICAL
TRIALS
Completed:
1. Upjohn: Alprostadil (PGE1), Sterile Powder for
Erectile Dysfunction: A Pilot
Study (Protocol 0065)
2. Upjohn: Dose-response Study with the New
Alprostadil Sterile Powder (PGE1)Formulation in Patients with
Erectile Dysfunction (Protocol 0069) 5/1/94-5/1/96
3. VIVUS: Dose-Ranging, Titration and Maintenance
Program for Treatment of Erectile Dysfunction with MUSE (Medicated Urethral
System for Erection)
4.
VIVUS: Program for Treatment of Erectile Failure with MUSE
(Medicated Urethral System for Erection):
Quality of Life
5. VIVUS: Evaluation of the Safety and Efficacy
of Alprostadil Administered by MUSE (Medicated Urethral System for Erection)
(Protocol 94-02)
6. Pentech: Apomorphine Hydrochloride, USP
Sublingual Tablet Escalating Dose Tolerance Study for the Treatment of
Psychogenic Erectile Disorder
7.
Syntex: A Randomized double-blind Placebo Controlled Parallel Study
to Assess the Efficacy and Safety of Four Oral Dose Levels of RS-15385-197 in
Men With Erectile Disorder
9. VIVUS: One-year Open-label evaluation of the
Safety and Efficacy of Alprostadil Administered by MUSE (Medicated Urethral
System for Erection) (Protocol 94-03)
10. long-term
Evaluation of the Safety and Efficacy of Alprostadil Administered by MUSE
(Medicated Urethral System for Erection) (Protocol 95-01)
11. Pfizer: A Randomized, Double-Blind, Placebo
Controlled, Parallel-Group, Fixed-Dose, Multicenter, Two-Month Dose-Response
Study to Assess The Efficacy and Safety of UK-92,480 Administered Prior to Sexual
Activities to Male Patients With Erectile Dysfunction (Protocol 148-101)
9/1/95-8/31/96
12.
A Randomized, Double-Blind, Placebo Controlled,
Parallel-Group, Fixed-Dose, Multicenter, Long-Term Dose-Response Study to
Assess The Efficacy and Safety of Sildenafil Administered Prior to Sexual
Activity to Male Patients With Erectile Dysfunction (Protocol 148-101B)
13.
An open, non-comparative extension study of
sildenafil in patients with erectile dysfunction (protocol 00-107) sponsored by
Pfizer. 9/1/98-8/31/02
14.
Research core and clinical site quality assurance
core for the erectile dysfunction pilot study. The Exploratory
Comprehensive Evaluation of Erectile Dysfunction (ExCEED) study.
Sponsored by Tap Pharmaceutical Products. 10/1/1999-8/8/2001
PATENTS
1. Lue TF, Tanagho EA, Schmidt
RA: Method and pacemaker for
stimulating penile erection. U.S.
Patent No. 4,585,005. Issued 4/29/86.
2. Tanagho EA Schmidt RA Gleason
CA, Lue TF: Method and system for
controlling bladder evacuation.
U.S. Patent No. 4,607,639. Issued 8/26/86.
3. Tanagho EA, Schmidt RA Gleason CA, Lue
TF: Control system for the stimulation of two bodily functions. U.S. Patent No.
4,703,755. Issued 11/3/87.
4. Lue, TF, Tanagho, EA, Schmidt RA and
Gleason CA: Method for stimulating pelvic floor muscles for regulating pelvic
viscera. U.S. Pat. No. 4,739,764. Issued
4/26/88.
5. Lue, TF, Tanagho, EA, Schmidt RA and
Gleason CA: Implantable system and method for augmenting penile erection. US
patent No. 4982731, issued 1/8/91
6. Tanagho EA, Schmidt RA, Gleason CA and
Lue TF: Surgically implantable peripheral nerve electrode. US Patent No.
4,940,065, July 10, 1990
7. Gleason CA, Stoller LS, Lue
TF, Schmidt RA, Tanagho EA: Implantable nerve stimulation device. US Patent No.
5,094,242. March 10, 1992
8. Gleason CA, Stoller LS, Lue
TF, Schmidt RA, Tanagho EA: Method for implanting electro-acupuncture needle.
US Patent No. 5,211,175. May 18, 1993
9.
Tanagho EA, Dahiya R, Lue TF and Cunha GR: Smooth
muscle tissue formation in vivo using cultured smooth muscle cells combined
with an extracellular matrix. US Patent No. 5,656,478. August 12, 1997
10.
Lue, TF, Lin C-S, Kan YW: Methods and compositions
for preventing and treating erectile dysfunction and female arousal disorder,
granted 1/13/04
SERVICE
TO PROFESSIONAL PUBLICATIONS:
1. Journal of Urology and
Investigative Urology - Ad hoc referee, 1985 - now
2. Neurology and Urodynamics -
Ad hoc referee, 1985 - now
3. Videourology-
Assistant editor, l987-2000
4. Journal of Urology, (Urological Survey
Section)-Editorial Board, 1989-1999
5. International
Journal of Impotence Research-Editorial Board Member, 1989-now
6. New Eng J Med. -Ad hoc referee, 1990
7. Ad hoc reviewer, Journal of Clinical
Ultrasound, 1991
8. Fertility and Sterility- ad
hoc reviewer, 1991, 1992, 1993
9. Journal of American Medical Association,
ad hoc reviewer, 1993
10. Journal of Andrology, ad hoc reviewer, 1993
11. Urology - Associate editor, 1993-
12. Urology International-Editorial Board Member, 1994- 1999
13. Journal of the Formosan Medical Association, guest
editorial board member, 1994-
14. Kaohsiung Journal of Medical Sciences, editorial
board member, 1994-
15. Western Journal of Medicine-- Ad hoc reviewer,
1995
16. Family Urology (American Foundation for Urological
Diseases)-Editorial Board Member, 1995-
17. Digital Urology, Editorial Board, 1996-
18. Molecular Urology, Editorial Board, 1997-2002
19. Sexual Dysfunction, Editorial
Board, 1997-
20. Associate
editor, Journal of Female Urinary Incontinence (Brazil), 1998-
21. Journal of Urology, ad hoc
reviewer, 1987-
19. Journal
of Sexual & Reproductive Medicine, International Editorial Board member,
2000-
20. Current
Urology Reports, Editorial Board member, 2000-
21. National
Journal of Andrology (China), associate editor, 2003-
PUBLICATIONS
1. Lue, T.F., Macchia, R.J.,
Vuletin, J.C., and Rosen, Y.:
Fibrosarcoma of penis.
Urology 15:498, 1980.
2. Lue, T.F., Macchia, R.J.,
Pastore, L., and Waterhouse, K.:
Vesicoureteral reflux and staghorn calculi. J. Urol. 127:247, 1982.
3. Lue, T.F., Takamura, T.,
Schmidt, R.A. and Tanagho, E.A.:
Potential preservation of potency after radical prostatectomy. Urology 22:165-167, 1983.
4. Hricak, H., Lue, T.F.,
Zeineh, S., Alpers, C. and Tanagho, E.A.:
Experimental study of the sonographic diagnosis of testicular
torsion. J. Ultrasound Med.
2:349-356, 1983.
5. Lue, T.F., Zeineh, S.,
Schmidt, R.A. and Tanagho, E.A.:
Physiology of penile erection.
World J. Urol. 1:194, 1983.
6. Lue, T.F., Schmidt, R.A. and
Straw, W.E.: Early recognition and
management of impotent patients.
Family Medicine Reports 1(10):59, 1983 (Nov).
7. Lue, T.F., Takamura, T.,
Schmidt, R.A., Palubinskas, A.J. and Tanagho, E.A.: Hemodynamics of erection in the monkey. J. Urol. 130:1237, 1983.
8. Lue, T.F., Takamura, T.,
Umraiya, M., Schmidt, R.A. and Tanagho, E.A.: Animal models for penile erection studies. Neurourology and Urodynamics 2:225,
1983.
9. Lue, T.F.: Erection pacemaker. Medical Aspects of Human Sexuality
(Questions and and Answers) 18:52, 1984 (Jan).
10. Lue, T.F., Schmidt, R.A., Tanagho, E.A. and
Zeineh, S.: Neuroanatomy of penile
erection: Its relevance to
iatrogenic impotence. J. Urol.
131:273-280, 1984.
11. Lue, T.F., Takamura, T., Umraiya, M., Schmidt,
R.A. and Tanagho, E.A.:
Hemodynamics of canine corpora cavernosa during erection. Urology 24:347-352, 1984.
12. Lue, T.L., Fahey, M.R., Lin, S.N., Schmidt, R.A.
and Tanagho, E.A.: Effects of
anesthesia on penile erection.
Surg. Forum 35:628-630, 1984.
13. Finkle, A.L. and Lue, T.F.: Benign prostatic hypertrophy and
absence of ejaculate. JAMA
(Q&A):253:94, 1985.
14. Carroll, P.R., Lue, T.F., Schmidt, R.A.,
Trengove-Jones, G. and McAninch, J.W.:
penile replantation:
Current concepts. J. Urol.
133:281-285, 1985.
15. Lue, T.F., Schmidt, R.A. and Tanagho, E.A.: Electrostimulation and penile
erection. Urol. Int. 40:60-64,
1985.
16. Lue, T.F.:
Editorial - Evaluation and treatment of impotence: Where are we going? West. J. Med. 142(4):546, 1985.
17. Lue, T.F., Hricak, H., Marich, K.W. and Tanagho,
E.A.: Evaluation of arteriogenic
impotence with intracorporeal injection of papaverine and the duplex ultrasound
scanner. Semin. Urol. 3(1):43-48,
1985.
18. Lue, T.F., Hricak, H., Marich, K.W. and Tanagho,
E.A.: Vasculogenic impotence
evaluated by high-resolution ultrasonography and pulsed Doppler spectrum
analysis. Radiology 155:777-781,
1985.
19. Rosen, L., Hoddick, W.K., Hricak, H. and Lue,
T.F.: Urachal carcinoma. Urol. Radiol. 7:174-177, 1985.
20. Lue, T.F. and Tanagho, E.A.: Functional evaluation of erectile
impotence: Akt. Urol. 16:244-249,
1985.
21. Lue, T.F., Schmidt, R.A. and Tanagho, E.A.: Erection pacemaker: In: Proceedings of the First World Meeting on Impotence. (Virag R., ed) CERI, Paris, 1985.
22. Lue, T.F., Hricak, H., Schmidt, R.A., Tanagho,
E.A.: Functional evaluation of
penile veins by cavernosography in papaverine induced erection. J. Urol. 135:479-482, 1986.
23. Lue, T.F., Hellstrom, W.J.G., and McAninch, J.W.,
and Tanagho, E.A.: Priapism: A refined approach to diagnosis and
treatment. J. Urol., 136:104,
1986.
24. Juenemann,
K-P., Lue, T.F., Fournier, G.R. Jr., Tanagho, E.A.: Hemodynamics of papaverine- and phentolamine-induced penile
erection: J. Urol. 136:158, 1986.
25. Abber, J.C., Lue, T.F., Orvis, B.R., McClure, R. D. and
Williams, R. D.: Diagnostic tests
for impotence - A comparison on papaverine injection with the penile brachial
index and nocturnal penile tumescence monitoring. J. urol. 135:923, 1986.
26. Juenemann,
K-P., Lue, T.F., Abozeid, M., Hellstrom, W. and Tanagho, E.A.: Blood gas analysis in drug induced
penile erections, Urol. Int. 41:207, 1986.
27. Juenemann,
K-P., Lue, T.F., Luo, K. and Tanagho, E.A.: Further evidence of venous outflow reduction during penile erection. Brit. J. Urol. 58:329, 1986.
28. Abber, J.C., and Lue, T.F.: Medical causes of impotence, J. Urol. Nurs. 5:595, 1986.
29. Lue, T.F.:
The erectile mechanism. In: Proceedings of the Conference on the
Scientific Basis of Sexual Dysfunction.
Washington, D.C.: U.S.
Government Printing Office #1986-491-292:41090.
30. Lue, T.F.:
Pharmacologic tools in evaluation.
In: Proceeding of
the Conference on the Scientific Basis of Sexual Dysfunction. Washington, D.C.: U.S. Government Printing Office
#1986-491-292:41090.
31. Hricak, H., Taylor, K.J., Marich, K., Lue, T.F.,
and Burns, P.: Doppler in
urology. In: Genitourinary Ultrasound. Clinics in Diagnostic Ultrasound
18:241-270, 1986.
32. Lue, T.F.:
Mechanism of penile erection in the monkey, Semin. Urol. 4:217, 1986.
33. Lue, T.F. and Tanagho, E.A.: Neurogenic etiology of impotence. In: Current Therapy in Genitourinary Surgery (Resnick, M.I. and
Kursh, E.D., eds.) Philadelphia,
PA: B.C. Decker, 1987, pp.
472-474.
34. Fournier, G. R., Juenemann, K-P, Lue, T.F., and
Tanagho, E.A.: Mechanisms of
venous occlusion during canine penile erection: An anatomical demonstration J. Urol. 137:163, 1987.
35. Stoller, M., Lue, T.F., and McAninch, J.W.: Constrictive penile band injury -
anatomical and reconstructive considerations. J. Urol.
137:740, 1987.
36. Abber, J.C. Lue, T.F., Luo, J.A., Juenemann, K-P.,
and Tanagho, E.A.: Priapism
induced by chlorpromazine and trazodone:
Mechanism of action. J.
Urol. 137:1039-1042, 1987.
37. Lue, T.F. and Tanagho, E.A.: Physiology of erection and
pharmacologic management of impotence.
J. Urol. 137:829-832, 1987.
38. Juenemann,
K-P., Lue T.F., Luo, J.A., Benowitz, N.L., Abozeid, M., and Tanagho, E.A.: Effect of cigarette smoking on penile
erection. J. Urol. 138:438-441,l987
39. Lue, T.F. and Zorgniotti, A.W.,:Patient Guide: Treatment for
impotence. Medical Aspect of Human Sexuality pp. 29-30, March, l987
40. Lue, T.F., Mueller, S.C., Juenemann, K.-P.,
Fournier, G.R. Jr., and Tanagho, E.A.:
Hemodynamic mechanisms of penile erection and functional evaluation of
penile arteries with duplex sonography and pulsed Doppler analysis. Akt. Urol. 18:115, 1987.
41. Hellstrom, W.J.G., Schmidt, R.A., Lue, T.F.,
Tanagho, E.A.: Neuromuscular
dysfunction in nonbacterial prostatis.
Urology 30: 183-188, l987.
42. Juenemann,
K.P., Lue, T.F. and Melchior, H.: Die Physiologie der penilen Erektion I.
Hemodynamik der penilen Erection.
Urologe A 26:283-288, l987.
43. Juenemann,
K.P., Lue, T.F. and Melchior, H.: Die Physiologie der penilen Erection II.
Neurophysiologie der penilen Erection. Urologe A 26:289-293, l987.
44. Orvis, B. and Lue, T.F.: New therapy for impotence. Urol. Clin N. Amer. 14:569-581, 1987.
45. Juenemann,
K-P, Luo, J.A., Judallah, S.A., Nunes, L.L., Lue, T.F. and Tanagho, E.A.: The role of vasoactive intestinal
polypeptide (VIP) as a neurotransmitter in canine penile erection: A combined in vivo and
immunohistochemical study. J.
Urol. 138:871-877, 1987.
46. Abozeid, M., Juenemann, K-P., Luo, J.A., Lue,
T.F., and Tanagho, E.A.: Chronic
papaverine treatment: The effect
of repeated injection on the simian erectile response and penile tissues. J. Urol. 138:1263-1266, l987.
47. Abber, J.C., and Lue, T.F.: Evaluation of impotence In Problems in Urology
(deVere White, R., ed.) Philadelphia:
J.B. Lippincott 1:476-486,
l987.
48. Hellstrom, W.J.G., McAninch, J.W., and Lue,
T.F.: Priapism: Physiology and treatment. In Problems in Urology (deVere
White, R., ed.) Philadelphia: J.B.
Lippincott 1:518-528, 1987.
49. Orvis, B.R., and Lue, T.F.: New therapy for impotence. In Advances in Urology, Vol. 1 (Lytton, B.,Catalona,
W.J. Lipshultz, L.I. and McGuire, E.J. eds.) Chicago: Year Book Medical Publishers, 1988, pp 173-191.
50. Mueller, S.C., and Lue, T.F.: Evaluation of vasculogenic
impotence. Urol. Clin. N. Amer.
15:65-76, 1988.
51. Fournier, G.R. Jr. and Lue, T.F.: Vasculogenic
impotence: physiology, diagnosis and treatment. Monographs in Urology, Stamey,
T. (ed.) 9:20-31, 1988.
52. Lue, T.F. and Abber, J.C.: Penodynamics: Diagnostic studies of vasculogenic impotence. In: Disorders of Male Sexual Function (Montague, D.K., ed.)
Chicago, IL: Year Book Medical
Publishers 1988, pp 95-104.
53. Lue, T.F.:
Male sexual dysfunction.
Ch. 37 in Smith's General Urology 12th edition, Norwalk, Conn.: Appleton & Lange (Tanagho, E.A. and
McAninch, J.W., eds.) 1988, pp 663-678.
54. Aboseif, S.R., and Lue, T.F.: Hemodynamics of penile erection. Urol. Clin. N. Amer. 15:1-7, 1988.
55. Lue, T.F. and Tanagho, E.A.: Hemodynamics of erection. In Contemporary Management of
Impotence and Infertility, Tanagho, E.A., Lue, T.F. and McClure, R.D. (eds.),
Williams & Wilkins, Baltimore, 1988, pp 28-38.
56. Lue, T.F. and Tanagho, E.A.: Functional anatomy and mechanism of
penile erection. Ibid., 1988, pp
39-50.
57. Lue, T.F.:
Pharmacology of erection and impotence. Ibid., 1988, pp 51-54.
58. Lue,T.F.:
Functional evaluation of penile arteries with papaverine. Ibid., 1988, pp 57-64.
59. Lue, T.F.:
Functional study of penile veins.
Ibid., 1988, pp 65-69.
60. Lue, T.F.:
Erection pacemaker. Ibid.,
1988, pp 157-159.
61. Zorgniotti, A.W. and Lue, T.F.: Intracavernous injection of papaverine
and phentolamine. Ibid., 1988, pp
160-161.
62. Lue, T.F.:
Office treatment:
papaverine injection for impotence. Ibid., 1988, p 162.
63. Lue, T.F.:
Treatment of venogenic impotence.
Ibid., 1988, pp 175-177.
64. Lue, T.F. and McAninch, J.W.: Priapism. Ibid., 1988, pp 201-210.
65. Juenemann,
K-P, Lue, T.F., Schmidt, R.A., and Tanagho, E.A.: Clinical significance of sacral and pudendal nerve
anatomy. J. Urol. 139:74-80, 1988.
66. Lue, T.F.:
Impotence--new concepts regarding therapy. In Current Trends in Urology, Vol. 4 Chapter 1, pp.
1-9 (Resnick, M.I., ed.) Baltimore:
Williams and Wilkins, 1988.
67. Marotti, M., Hricak, H., Lue, T.F., Wetzel, L.,
McAninch, J.A., and Tanagho, E.A.:
Magnetic resonance imaging in the evaluation of the penis: Normal anatomy and various abnormal
penile conditions . Radiology 169:683-690, 1988.
68. Mueller, S.C., Hsieh, J.T., Lue, T.F. and Tanagho,
E.A.: Castration and
erection: An animal study. Eur. Urol. 1988; 15:118-124.
69. Stief, C.G., Diederichs, W., Benard, F., Bosch,
R., Lue ,T.F. and Tanagho, E.A.: The
diagnosis of venogenic impotence:
Dynamic or pharmacologic cavernosometry? J. Urol. 140:1561-1563, 1988.
70. Stief, C.D., Benard, F., Diederichs, W., Bosch,
R., Lue, T.F., and Tanagho, E.A.:
The rationale for pharmocologic cavernosography. J. Urol. 140:1564-1566, 1988.
71. Hricak,
H., Marotti, M., Gilbert, T.J., Lue, T.F., Wetzel, L., McAninch, J.W., and
Tanagho, E.A.: Magnetic resonance
imaging in the evaluation of the penis: Normal anatomy and various abnormal
penile conditions. Radiology
169: 683-690, 1988.
72. Aboseif, S.R., and Lue, T.F.: Fundamentals and hemodynamics of penile
erection. J. Cardiovasc.
Intervent. Radiol. 11:185-190,
1988
73. Lue,
TF: Impotence, AUA Decision Making
Series, American Urological Association, Baltimore, MD , Vol. II 1988
74. Workman, S.J. and Lue, T.F.: Impotence in diabetics. In Practical Aspect of Diabetic
Management, Siperstein, M.D. (ed.), HP Publishing Company, New York, 1989, pp
1-12.
75 Aboseif, S.R., Breza, J., Orvis, B.R., Lue,
T.F. and Tanagho, E.A.: Erectile
response to acute and chronic occlusion of the internal pudendal and penile
arteries. J. Urol. 141:398-402,
1989.
76. Breza, J, Aboseif, SR, Orvis, BR, Lue, TF and
Tanagho, EA: Detailed anatomy of
penile neurovascular structures:
surgical significance. J.
Urol. 141:437-443, 1989.
77. Lue, T.F., Carroll, P.R. and Moore C.: The treatment of impotence in cancer
patients. In Important
Advances in Oncology: 1989 (DeVita V.T. Jr., Hellman S., and Rosenberg, S.A.,
eds.) Philadelphia: Lippincott pp. 193-203, 1989
78. Nelson RP and Lue TF: Determination of erectile penile volume
by ultrasonography. J Urol. 141:1123-1126, 1989.
79. Mueller, SC, Aboseif S, Fahey MR, Lue, TF and Tanagho, EA: Spinal anesthesia and electroerection
in dogs and monkeys. J. Urol.
142:171-175, 1989.
80. Aboseif S.R., Breza J, Bosch RJLH, Benard, F,
Stief CG, Stackl W, Lue, T.F., and Tanagho, E.A.: Local and systemic effects of chronic intracavernous
injection of papaverine, prostaglandin E 1 and saline in primates. J. Urol. 142: 403-408, 1989.
81. Juenemann,
KP, Persson-Juenermann C, Lue, TF, Tanagho, EA and Alken P: Neurophysiological
aspects of penile erection: the role of the sympathetic nervous system. Brit.
J. Urol. 64:84-92, 1989.
82. Hsieh, J.T., Muller, S.C. and Lue, T.F.: The influence of blood flow and blood
pressure on penile erection Int.J.
Impotence Res 1:35-42,1989.
83 Lue, T.F.: Penile venous surgery . Urol Clin N. Amer. 16:607-611, 1989.
84. Stief, C., Benard, F., Bosch R., Aboseif, S.,
Nunes, L. Lue, T.F. and Tanagho, E.A.:
Acetylcholine as a possible neurotransmitter in penile erection. J. Urol. 141:1444-1448, 1989
85. Lue, T.F.:
Penile venous surgery.
Seminars in Interven. Radio. 6:227-230, 1989.
86. Lue, T.F.:
Patient's goal-directed impotence management. Urology Grand Rounds
29:1-5, 1989.
87 Chandhoke,P
& Lue, TF: Mathematic model of penile erection. Int. J. Impotence Res.
1:137-144, 1989.
88. Persson, H., Lue, T.F., Yen, S.B., and Tanagho,
E.A.: Correlation of altered penile
ultrastructure with clinical arterial evaluation. J. Urol. 142:1462-1468, 1989.
89. Lue, T.F., Mueller, S.C., Jow, Y.R., and Hwang,
T.I.: Functional evaluation of
penile arteries with duplex ultrasound in vasodilator-induced erection. Urol Clin N Amer. 16:799-807, 1989.
90. Vapnek,J and LueTF: Heterotopic bone formation in
the corpus cavernosum: a complication of papaverine-induced priapism. J. Urol.
142:1323-1324, 1989.
91. Aboseif, SR, Breza, J, Lue, TF, and Tanagho,
EA: Penile venous drainage in
erectile dysfunction: anatomical, radiological and functional
considerations. Brit. J. Urol.
64:183-190,1989.
92. Broderick, G.A. and Lue, T.F.: Priapism and the physiology of
erection. AUA Update Series 1989.
93. Diederichs, W., Kaula, N.F., Lue, T.F., and
Tanagho, E.A.: The effect of
subatmospheric pressure on the simian penis. J. Urol.142:1087-1089, 1989.
94. Hwang TI, Lue TF, Yang CR, Chang CL, Chang CH and Wu HC:
Comparison of penile vascular effect induced by intracavernous injection of
papaverine and prostaglandin E 1. J Formosan Med Assoc 88; 1038-41, 1989
95. Broderick, GA and Lue, TF: Treatment of priapism. In Current Problems in
Infertility and Impotence.
(Rajfer, J., ed.), Year Book Medical Publishers 290-299, 1990.
96. Benard, F. and Lue, T.F.: Arterial evaluation (non-invasive) of
impotence. Ibid. 258-267, 1990.
97. Lue, T.F.:
Surgery for venous occlusion.
Ibid. 311-316,1990.
98. Benard, F and Lue, TF: Pharmacologic treatment of impotence:
Autoinjection program. Contemporary Urol pp.21-26, Jan/Feb, 1990
99. Stackl W, Stief CG, Benard F, Aboseif SR, Bosch RJLH, Loupal
G, Lue, TF and Tanagho, EA: Intracavernous injections of solutions with
different osmolarity and pH in the rabbit. Int. J. Impotence Res. 1:197-200,
1990.
100. Bosch
RJLH, Benard F, Aboseif SR, Stief CG, Stackl W, Lue TF and Tanagho E: Changes
in penile hemodynamics after intracavernous injection of prostaglandin E 1 and
prostaglandin I 2 in pigtailed monkeys. Int. J. Impotence Res. 1:211-221, 1990.
101. Stief
CG, Benard F, Bosch RJLH, Aboseif SR, Lue TF and Tanagho, ET: A possible role
fo calcitonin-gene-related peptide in the regulation of the smooth muscle tone
of the bladder and penis. J. Urol 143:392-397, 1990.
102. Tanagho,
E.A., and Lue, T.F.: Physiology of
penile erection. In
Scientific Foundations in Urology (Chisholm, G., and Fair, W.R., eds.) 3rd Ed.,
Chicago: Year Book Medical
Publishers Third edition pp.420-426, 1990
103. Benard,
F. and Lue, T.F.: Pharmacologic
treatment of impotence: Self
administration. Drugs, 39:394-398,
1990, (New Zealand)
104. Lue
TF: Intracavernous drug administration: Its role in Diagnosis and Treatment of
Impotence. Seminars in Urol.8: 100-106, 1990
105. Aboseif
SR, Lue TF: Sexual dysfunction following cororectal surgery, Perspectives in
Colon and Rectal Surgery
3:157-172, 1990
106. Lue
TF: Impotence: A patient's goal-directed approach to treatment. World J Urol
8:67-74, 1990
107. Carroll
PR, Lue TF, Narayan P and Tanagho,
EA: Impotence and incontinence after radical prostatectomy: pathophysiology and
management. In Treatment Perspectives in Urologic Oncology. Wiliams RD and
Carroll PR (Eds) Pergamon Press, New York, Chapter 10, pp161-180, 1990.
108. Nelson,
R.P. and Lue, T.F.: Functional
evaluation of penile erection. In
Diagnostic Techniques in Urology, (O'Reilly, P.H., George, N.J.R. and Weiss,
R.M., eds.) London: Grune & Stratton , Chap. 18, 285-92, 1990.
109. Aboseif,
S.R., Wetterauer, U., Breza, J., Benard, F., Bosch, R., Lue, T.F., and Tanagho,
E.A.: The effect of venous
incompetence and arterial insufficiency on erectile function: and Animal model. J Urol 144:790-3, 1990
110. Lue
TF: Update on impotence research. Int J Impotence Res (1990) 2,Suppl 1:7-8
111. Diederichs W, Stief CG, Lue TF and
Tanagho EA: Norepinephrine involvement in penile detumescence. J Urol
143:1264-6, 1990
112. Mersdorf A, Goldsmith PA, Diederichs W,
Padula CA, Lue TF, Fishman IJ and Tanagho EA: Ultrastructural changes in
impotent penile tissue: comparison of 65 patients. J Urol. 1991; 145:749-758.
113. Lue
TF:Impotence after radical pelvic surgery: physiology and management. Urol Int.
1991;46:259-265
114. Lue
TF: Organic impotence. In Current Therapy in Endocrinology and Metabolism, C.
W. 4th edition,Bardin (ed). p. 296-301, 1991
115. Batra
AK and Lue TF: Physiology and
pathology of penile erection. Annual Review of Sex Research 1:251-263, 1990
116. Lue
TF:
Impotence after prostatectomy.
Urologic Clinics of North America, 1990 Aug, 17(3):613-20.
117. Breza
J; Aboseif SR; Lue TF; Tanagho EA.: Cavernous vein arterialization for
vasculogenic impotence. An
animal model. Urol, 1990 Jun,
35(6):513-8.
118. Lue,
TF: This month in investigative urology: restoration of erectile function by
cavernous nerve graft. J Urol
1991; 145:378-9.
119. Mueller
SC, El-Damanhoury H, Rueth J and Lue, TF: Hypertension and impotence. European
Urol 1991; 19:29-34.
120. Takahashi
Y, Hirata Y, Yokoyama S, Ishii N, Nunes L, Lue TF and Tanagho EA: Loss of
penile erectile response to intracavernous injection of acetylcholine in
castrated dog. Tohoku J. Exp Med, 1991; 163:85-91
121. Diederichs
W, Stief CG, Lue TF, Tanagho EA: Sympathetic inhibition of papaverine induced
erection. J Urol 146:195-198,1991
122. Lue,
TF and Hricak,H: Ultrasonography of the penis,In Ultrasound of the Urinary
System, (Resnick, MI & Rifkin MD eds.) Williams & Wilkins, Baltimore,
p. 336-348, 1991.
123. Lue,
T.F: Incidence and mechanism of
impotence after prostatectomy.
Urol Clin N Amer. 17:613-620, 1991
124. Abber,
J.C. and Lue, T.F.: Extravaginal
torsion of the spermatic cord in an adult. Urology 38:79-81,1991
125. Lue
TF: Physiology of penile erection. In Impotence, Jonas U, Thon W, Stief C (eds)
Springer-Verlag Heidelberg
pp.44-56, 1991
126. Broderick
GA and Lue TF: The penile blood flow study: evaluation of vasculogenic
impotence by duplex ultrasound. In Impotence, Jonas U, Thon Stief C (eds)
Springer-Verlag Heidelberg pp.
126-136, 1991
127. Diederichs
W, Lue TF, TRanagho EA: Clitoral response to cavernous nerve stimulation in
dogs. Int J Impotence Res. 3:7-13, 1991
128. Stief
CG, Bosch R, Diederichs W, Bernard F. Padula C, Goldsmith PC, Lue TF, Tanagho
EA: Cavernous smooth muscle changes during penile erection and sympathetic stimulation.
Int J Impotence Res. 3:15-20, 1991
129. Bosch
BJL, Benard F, Aboseif SR, Stief CG, Lue TF, Tanagho EA: Penile detumescence:
characterization of three phases. J Urol 146:867-871,1991
130. Floth
A, Paick JS, Suh JK, Lue TF: Hemodynamics of revascularization of the corpora
cavernosa in an animal model. Urol Res 19:281-284, 1991
131. Takahashi
Y, Ishii N, Lue TF, Tanagho EA: Pharmacological effects of adenosine on canine
penile erection. Tohoku J Exp Med 165:49-58, 1991
132. Diederichs
W; Lue TF:Reduction of sympathetic influences on penile erection by phentolamine.Urologia
Internationalis, 1991, 46(1):64-6.
133. Diederichs
W; Stief CG; Benard F; Bosch R; Lue TF; Tanagho EA.The sympathetic role as an antagonist
of erection.Urological Research, 1991, 19(2):123-6.
134.
Lue TF : Arterial etiology of impotence.
In: Current Therapy
in Genitourinary Surgery (Resnick, M.I. and Kursh, E.D., eds.) Mosby-year Book, St. Louis. p.528-532, 1992.
135. Hsieh
J-U, Mueller SC, Lue TF: Hemodynamics of canine corpus spongiosum during pelvic
and pudendal nerve stimulation. Int J Impotence Res 1992; 4:3-9.
136. Symposium
:Vasoactive drugs in the workup of impotence. Contemp Urol 1992;4:31-44
137. Paick JS, Donatucci CF, Marc B,
Hohenfellner M, Lue TF, Tanagho, EA: Hemodynamics of deep dorsal vein
arterialization with implantation of a penile venous compression device:
Initial experience in the canine
model. Int J Impotence Res
1991;3:181-191
138. Lue,
T.F.: Male sexual
dysfunction. In Smith's General
Urology 13th edition, Norwalk, Conn.:
Appleton & Lange (Tanagho, E.A. and McAninch, J.W., eds.) Chap.44
p.696-713,1992
139. Paick
J-S, Goldsmith PC, Batra AK, Nunes LL, Padula CA and Lue, TF: Relationship
between venous incompetence and cavernous nerve injury: ultrastructural
alteration of cavernous smooth muscle in the neurotomized dog. Int J Impotence
Res 1991; 3:193-203
140. Batra
AK and Lue TF: Penile erection:
circulatory physiology, In The diagnosis and management of male erectile
dysfunction Kirby RS, Carson C Webster GD (eds), Butterworths, London p.19-26,
1992
141.
Donatucci,
C.F., and Lue, T.F: Correction of Penile Deformity Assisted by Intracavernous
Injection of Papaverine, J Urol 147:1108-1110, 1992
142. Lue
TF: Physiology of penile erection and pathophysiology of impotence. In Sixth
edition, Campbell's Urology (Walsh PC, Retik AB, Stamey TA, Vaughan ED, Jr.
editors). W.B. Saunders,
Philadelphia p. 707-728, 1992
143. Lue,
TF: Surgical treatment of impotence (special comment), In Master of
Surgery:Urology, (Fowler, JE,Jr. ed) Little, Brown & Company. p. 451-4,
1992
144. Donatucci
C and Lue TF: New diagnostic procedures for evaluation of impotence: In Report
on Urologic Techniques. Assimos DG and Kroovand RL (Editors), Churchill Livingstone 2: 37-40 May 1992
145. Lue:
Diagnostic method on impotence. Problems in Urology 5: 519-522, 1991
146. Batra
AK and Lue TF: Physiology of
penile erection ,Problems in Urology 5:489-495, 1991
147. Brock
GB, Lue, TF: Sexual dysfunction following pelvic surgery. Trends inUrology
(Japan) 3:4-5, 1992
148. Aboseif
S, Baskin L, Yen TSB, Lue,TF: Congenital defect in sinusoidal smooth muscles :
A cause of organic impotence. J
Urol 148:58-60,1992
149. Donatucci
CF, Lue TF: The combined intracavernous injection and stimulation test:
diagnostic accuracy. J Urol 148:61-62, 1992
150. Paick JS, Marc B, Suh JK,
Batra AK, Lue TF and Tanagho EA: Implantable penile venous compression device:
initial experience in the acute canine model. J Urol 148:188-191, 1992
151. Takahashi
Y, Aboseif SR, Benard F, Stief CG, Lue TF and Tanagho EA: Effect of
intracavernous simultaneous injection of acetylcholine and vasoactive
intestinal polypeptide on canine penile erection. J Urol 148:446-448, 1992
152. Brock
J. and Lue, T.F.: Impotence: a patient's goal-directed approach. Monographs in
Urology, Stamey, T. (ed.) , 13: 99-110, 1992
153. Paick JS and Lue TF: Anatomy of the
penis. In: The penis Hashmat & Das (eds) Lea & Febiger, Malvern,
Pennsylvanis. pp 12-16, 1992
154. Donatucci CF and Lue TF: Chap. 3.
Physiology of penile tumescence. In: The penis Hashmat & Das (eds) Lea
& Febiger, Malvern, Pennsylvanis. pp 17-22, 1992
155. Takahashi
Y, Ishii N, Lue TF, Tanagho EA: The effects of adenosine on canine penile
erection. J Urol 148:1323-25,1992
156. Lue
TF: Pharmacology and pharmacotherapy of erections. In: The assessment and
treatment of erectile impotence. P Stricker and D Richardson (eds) Excerpta
Medica, Australia. p 6, 1992
157. Lue
TF: What is the role of nocturnal penile tumescence testing? In: The assessment and treatment of
erectile impotence. P Stricker and D Richardson (eds) Excerpta Medica,
Australia. p 15, 1992
158. Lue
TF: Vacscular assessment (venous and arterial) In: The assessment and treatment
of erectile impotence. P Stricker and D Richardson (eds) Excerpta Medica,
Australia. p 16, 1992
159. Lue
TF: Patient's goal-directed diagnosis.
In: The assessment and treatment of erectile impotence. P Stricker and D
Richardson (eds) Excerpta Medica, Australia. p 25, 1992
160. Lue
TF: Venous surgery: patient selection
In: The assessment and treatment of erectile impotence. P Stricker and D
Richardson (eds) Excerpta Medica, Australia. p 45, 1992
161. Lue
TF: Peyronie's disease: surgical treatment. In: The assessment and treatment of
erectile impotence. P Stricker and D Richardson (eds) Excerpta Medica,
Australia. p 48, 1992
162. Takahashi
Y, Ishii N, Lue TF, Tanagho EA: Effects of adenosine triphosphate on canine
penile erection. Int J Impotence Res 1992; 4:27-34
163. Wolf JS, Lue TF:
High-flow priapism and glans
hypervascularization following deep dorsal vein arterialization for
vasculogenic impotence. Urol Int
1992; 49:227-229
164. Martinez-Pineiro L;
Trigo-Rocha F; Hsu GL; Lue TF; Schmidt RA; Tanagho EA: Response of bladder,
urethral and intracavernous pressure to ventral lumbosacral root stimulation in
Sprague-Dawley and Wistar rats.
J Urol, 1992 Sep, 148(3):925-9.
165.
Donatucci,
C.F., and Lue, T.F: Penile Venous Surgery: Are We Kidding Ourselves?, in World
Book of Impotence, Smith-Gordon and Company, Ltd , Lue, T.F., editor, p.
221-227, 1992.
166. Donatucci CF, Lue TF:
Vascular reconstructive surgery of erectile dysfunction. Infections in Urology
5(5):150-5, 1992
167. Lue, TF: What constitute an
adequate impotence work-up? in World Book of Impotence, Smith-Gordon and
Company, Ltd , Lue, T.F., editor,p. 149-155, 1992
168. Hsu
G-L, Brock G, Martinex-Pineiro L, Von Heyden B, Lue TF and Tanagho EA: The
three dimentional structure of the human tunica albuginea: anatomical and
ultrastructural levels. Int J Impotence Research. 4:117-129, 1992
169. Dahiya R, Trigo-Rocha F,
Brock G, Narayan P, and Lue TF: Sodium nitroprusside and neurostimulation cause
increased levels of cyclic guanosine monophosphate and not cyclic adenosine
monophosphate during canine penile erection. Biochemistry International
29:167-173,1993.
170. Donatucci CF, Lue TF: The
effect of chronic vacuum constriction device usage on cavernous artery
function. Int. J Impotence Res. 4:149-155, 1992.
171. Donatucci C and Lue TF: Erectile
and ejaculatory function. In Reconstructive Urology. Blackwell
Scientific Publication,s, Ltd., Webster, G., Kirby, R., Goldwasser, B, and King
L.R., editors, Chapter 6, pp 71-78, 1993.
172. Donatucci
CF, Lue TF: Pathophysiology of sexual dysfunction in males with physical
disabilities. In: Reproductive issues for the physically disabled. Paul H
Brookes, Co. Baltimore. pp. 291-310, 1993.
173. Trigo-Rocha
F, Aronson WJ, Hohenfellner M, Ignarro LI, Rajfer J and Lue TF: Nitric oxide and cyclic
Guanosine Monophasphate: Mediatros of pelvic nerve-stimulated erection in dogs.
Amer J Physiol 264 (Heart Circ. Physiol 33): H419-H422, 1993
174. Trigo-Rocha
F, Hsu GL, Donatucci CF and Lue, TF: The role of cyclic AMP, cyclic GMA,
endothelium and non-adrenergic non-cholinergic neurotransmission in canine
penile erection. J Urol 149:
872-877, 1993
175. Aboseif S, Riemer RK Stackl W, Lue TF,
Tanagho EA: Quantification of prostaglandin E 1 receptors in the cavernous
tissue of humans, primates and canines.
Urol Int 50:148-152,1993
176. Breza J, Aboseif S, Lue, TF: Anatomy of the penis. Atlas of the Urol
Clinics of North America 1:1-8, 1993
177. Donatucci CF, Trigo-Rocha F,
Paick J-S, Lue TF, Tanagho EA: Implantable penile venous compression device:
initial experience in the chronic canine model. J Urol 149:1152-5, 1993
178. Lue TF: Editorial. Erectile
dysfunction: problems and challenges.
J Urol 149:1256-7, 1993
179. Armenakas NA, McAninch JW,
Lue TF, Dixon CM and Hricak H: Post-traumatic impotence: magnetic resonance
imaging and duplex ultrasound in diagnosis and management. J Urol 149:
1272-5,1993
180. von Heyden B, Donatucci CF,
Kaula N and Lue TF: Intracavernous pharmacotherapy for impotence: selection of
appropriate agent and dose. J Urol 149:1288-1290, 1993
181. Fournier
GR, Jr, Lue TF and Tanagho EA: Peyronie's plaque: surgical treatment with the
CO 2 laser and a deep dorsal vein patch graft. J Urol 149:1321-5, 1993
182. Stief
CG, Benard F, Bosch RJLH, Aboseif S, Wetterauer U, Lue TF and Tanagho EA:
Calcitonin Gene-related peptide: A possible neurotransmitter that contributes
to penile erection in monkeys. Urol 41:397-401, 1993
183. Donatucci
CF, Lue TF: Erectile dysfunction in men under 40 : etiology and treatment
choice. Int J Impotence Research 5:97-104, 1993
184. Hsu GL, Brock G, Trigo-Rocha F,
Martinez-Pineiro L, Lue TF: Combined cavernous compression device and arteriovenous-cavernous fistula: a
chronic canine model. J Urol 149:1564-1567,1993.
185. Brock G, Breza J, Lue TF and
Tanagho EA: Intracavernous sodium nitroprusside: inappropriate impotence
treatment . J Urol 150:864-867, 1993
186. Brock G and Lue TF:
Drug-induced sexual dysfunction: an update. Drug Safety 8(6) 414-426, 1993
187. Brock
G, Breza J, Lue TF and Tanagho EA: Prolonged high flow priapism: a spectrum of
disease. J Urol 150: 968-971,1993
188. Paick
J-S, Donatucci CF and Lue TF: Anatomy of
cavernous nerves distal to prostate: microdissection study in adult male
cadavers. Urology 42:145-149,1993
189. Brock
G, Kadioglu A and Lue, TF: Peyronie's disease: a modified treatment approach.
Urol 42: 300-304, 1993
190. Brock
G, Nunes L, von Heyden B, Martinez-pineiro L, Hsu G-L and Lue TF: Can venous
patch graft be a substitute for tunica albuginea of the penis?. J Urol
150:1306-1309, 1993
191. Brock G, Nunes L, Padma-Nathan H, Boyd S, Lue
TF: Nitric oxide synthase: a new diagnostic tool for neurogenic impotence. Urol
42: 412-417, 1993
192. Carrier
S, Brock G, Kour NW and Lue, TF: The pathophysiology of erectile dysfunction.
Urol 42: 468-481, 1993
193. Dahiya R; Sikka S; Hellstrom WJ;
Hayward SW; Narayan P; Tanagho EA; Lue TF.: Phenotypic and cytogenetic
characterization of a human corpus cavernosum cell line (DS-1). Biochem Mol Biol Int, 1993 Jul,
30(3):559-69.
194. Von
Heyden B, Lue TF : A prostaglandin E 1 dose-response study in man. J Urol
150:1825-1828, 1993
195. Lue
TF: Organic impotence. In Current Therapy in Endocrinology and Metabolism, C.
W. 5th edition,Bardin (ed). p. 329-333, 1994
196. Donatucci CF, Lue TF: The
management of impotence in older men. In: Urology in the Elderly (O'Donnell PD,
editor), Little, Brown and Company, p345-355, 1994
197. Donatucci
CF, Lue TF: Dysfunction of the veno-occlusive mechanism. in
Impotence:principles, diagnosis and
management, Bennett A (ed). W.BSaunders, Philadelphia. p.197-204, 1994
198. O'Leary
MP and Lue TF: Penile function. In Pathophysiologic principles of urology. Sant
GR edi. Blackwell Scientific Publications, Cambridge MA. p.181-207,1994
199. Trigo-Rocha
F, Hsu GL, Donatucci CF, Lue TF, Tanagho EA: The intracellular mechanism of
penile erection in monkeys.
Neurourol and Urodynamics 13:71-80, 1994
200. Martinez-Pineiro
L, Brock G, Trigo-Rocha F, Hsu GL, Lue TF and Tanagho EA: A rat model for the
study of penile erection: pharmacoloigic and electrical-stimulation parameters.
Eur Urol 25:62-70,1994
201. Lue
TF: Expert Opinion in erectile dysfunction. Urol Int 1:2-3, 1994.
202. Lue
TF: Erectile dysfunction associated with cavernous and neurological disorders.
(editorial) J Urol 151:890-891, 1994
203. Hsu
G-L, Brock G, Martinex-Pineiro L, Von Heyden B, Lue TF and Tanagho EA: Anatomy
and strength of the tunica albuginea: its relevance to penile prosthesis
extrusion. J Urol 151:1205-1208, 1994
204. Lue TF: Work-up of the
impotent male and selection of therapy. In Current Urologic Theray Vol. 3,
Seidmon EJ, Hanno PM, (eds) W.B. Saunders Company,p. 465-468, 1994
205. Marshall
GA, Breza J, Lue, TF: Improved hemodynamic response after long-term
intracavernous injection for impotence. Urol 43:844-848, 1994
206. Donatucci,
CF and Lue TF: Sexual dysfunction due to vascular disease. In Sexual
Dysfunction-A Neuro-Medical Approach.
Singer C and Weiner WJ (eds), Armonk, NY, Futura Publishing Co. pp.
275-297, 1994
207. Donatucci
C and Lue TF: Treatment of impotence. In Clinical Urology. Krane RJ, Siroky MB
and Fitzpatrick (editors) J.B. Lippincott pp. 1234-1244, 1994
208. Akkus
E, Carrier S, Rehman J, Breza J, Kadioglu A and Lue TF: Is colchicine effective
in Peyronie's disease? a pilot study. Urol 44: 291-295, 1994
209. Donatucci
CF, Lue TF: Treatment of priapism. Chap. 10. In: Management of impotence and
infertility. (Whitehead ED, Nagler HM eds.) J.B.Lippincott, p. 122-132, 1994
210. Carrier
S, Lue TF: For Peyronie's disease, act conservatively. Contemporary Urol; 6:
54-65, 1994.
211. Hsu, G-L, Brock G, Von Heyden
B, Nunes L, Lue TF and Tanagho EA: The distibution of elastic fibrous elements
within the human penis. Br J Urol, 73:566-571, 1994
212. Carrier
S, Zvara P and Lue TF: Erectile dysfunction. In Endocrinology and Metabolism
Clinics of North America 23:773-782, 1994.
213. Wolf,
JS, Brock GB, Gleason CA, Zvara P, Lue, TF, Carroll, PR: Laparoscopically
implantable nerve stimulating electrode (Linse): application to the cavernous
nerve in acute and chronic canine models. J Endourol 8:375-8, 1994
214. Carrier
S, Zvara P , Nunes L, Kour NW, Rehman J and Lue TF: Regeneration of nitric
oxide synthase-containing nerves after cavernous nerve neurotomy in rat. J Urol
153:1722-7, 1995.
215. von
Heyden B, Riemer RK, Nunes L, Brock GB, Lue TF and Tanagho EA: Response of
guinea pig smooth and striated urethral sphincter to cromakalim, prazosin,
nifedipine, nitroprusside, and electrical stimulation. Neurourol and
Urodynamics, 14:153-168, 1995.
216. Lue,
T.F.: Male sexual
dysfunction. In Smith's
General Urology 14th edition, Norwalk, Conn.: Appleton & Lange (Tanagho, E.A. and McAninch, J.W.,
eds.), 1995, pp.772-792.
217. Tanagho
EA and Lue, T.F.: Neuropathic
bladder disorders. In
Smith's General Urology 14th edition, Norwalk, Conn.: Appleton & Lange (Tanagho, E.A. and McAninch, J.W.,
eds.) 1995, pp. 496-513.
218. Lue
TF: A patient's goal-directed approach to erectile dysfunction and Peyronie's
disease. Can J Urol 2 (Supp1):13-17, 1995 (supplement)
219. Carrier
S, Hricak H, Lee S, Baba K, Morgan
DM, Nunes L, Phillips T, Ross GY and Lue TF: Radiation-induced
decrease in nitric oxide synthase-containing nerves in the rat penis.
Radiology, 1995 Apr, 195(1):95-9.
220. Trigo-Rocha F, Martinez-Pineiro L,
Donatucci CF, Hsu GL, Lue TF, Tanagho EA: Sodium nitroprusside: physiologic
effects as a nitric oxide donor in three species. Int J Impotence Research 6:
49-56, 1995.
221. Trigo-Rocha F, Donatucci CF,
Hsu GL, Nunes L, Lue TF, Tanagho EA: The effect of intracavernous injection of
potassium channel openers in monkeys and dogs. Int J Impotence Research
6:41-48, 1995
222. Lue TF and Levine JD:
Impotence. (editorial) J Urol 154:85, 1995.
223. Martinez-Pineiro L, Dahiya R,
Brock GB, Hsu GL, von Heyden B, Lue TF: Chronic penile denervation in the rat:
effect on cavernous tissue morphology and function. Int J Impotence Research
7:165-174, 1995.
224. Lue TF, Gleason C, Brock G,
Carroll P, and Tanagho EA:
Intraoperative neurostimulation of the cavernous nerves: technique, results and
limitations. J Urol 154:1426-1428, 1995
225. Akkus
E; Carrier S; Turzan C; Wang TN; Lue TF. Duplex ultrasonography after
prostaglandin E1 injection of the clitoris in a case of hyperreactio luteinalis. J Urol153(4):1237-8,
1995
226. Gluckman GR, Lue TF: Pelvic
steal syndrome. Urol 47:426, 1996
227. Wessells H, Lue TF, McAninch JW: Complications
of penile lengthening and augumentation seen at one referral center. J Urol 155:1617-1620, 1996
228. Deirmenjian
JM and Lue, TF: Surgical Treatment of Peyronie's disease. Western J Med.
164:344, 1996.
229. Wessells
H, Lue TF, McAninch JW: Penile
length in the flaccid and erect states:
Guidelines for penile augmentation. J Urol 156:995-997, 1996
230. Baskin
LS, Duckett JW, Lue TF: Penile
curvature. Urol 48:347-356, 1996
231. Turek
P and Lue, TF: Penile revascularization. in Atlas of the Urol Clinics of N
Amer. 4:129-142, 1996.
232. Aboseif S, Lue TF: Impotence following urethral
injury: etiology and diagnostic methods. In Traumatic and Reconstructive
Urology. JW McAninch (editor) pp. 455-462, 1996.
233. Breza J and Lue TF: Penile
revascularization for traumatic impotence. Ibid, pp. 463-470, 1996.
234. Brock G and Lue TF: Surgical
reconstruction of venogenic impotence. Ibid, pp. 471-478, 1996.
235. Brock G and Lue TF: Traumatic
priapism. Ibid, pp. 479-484, 1996.
236. Chang JJ and Lue, TF: Venous
Impotence. In Topics inClinical Urology. Diagnosis and Management of Male
Sexual Dysfunction. John J. Mulcahy (ed) Igaku-Shoin. New York,pp. 148-163,
1996.
237. Borirakchanyavat
S. and Lue, T.F.: Erectile Dysfunction. In Conn's Current Therapy , ,
W.B.Saunders Company, Philadelphia,
Rakel RE (ed), 1996, pp. 694-7.
238. Hellstrom WJG, Bennett AH, Gesundheit N,
, Kaiser FE, Lue TF et al: A
double-blind placebo-controlled evaluation of the erectile response to
transurethral alprostadil. Urol 48:851-6, 1996.
239. Connolly JA, Borirakchanyavat S, Lue TF:
Ultrasound evaluation of the penis for assessment of impotence. J Clin
Ultrasound 24:481-6, 1996.
240. Lue
TF: Veno-occlusive dysfunction of corpora cavernosa: comparison of
diagnostic methods.
J
Urol 1996 155 :786-7, 1996.
241. Brock G, Hsu G-L, Nunes L,
von Heyden B and Lue, TF: The anatomy of the tunica albuginea in the normal
penis and Peyronie's disease. J Urol 157:276-281, 1997.
242. Borirakchanyavat
S. and Lue, T.F.: Evaluation of impotence. Infections in
urology. 10:12-23, 1997.
243. Padma-Nathan H, Hellstrom WJG, Kaiser FE,
Labasky RF, Lue TF et al: Treatment of men with erectile dysfunction with
transurethral alprostadil Medicated urethral system for erection (MUSE). NEJM
336:1-7, 1997.
244. El-Sakka AI and Lue TF: Does
heart attack mean the end of
sexual life? American College of Cardiology Educational Highlight, 12:6-9,
1996.
245. von
Heyden B, Lue TF and Tanagho EA: Intracavernous injection of linsidomine
chlorhydrate in monkeys: lack of toxic effect with long-term use. Uuropean Urol
30:502-5, 1996
246. Lue TF, Akkus E and Kour NW: Physiology
of erectile function and dysfunction. Campbell's Urology Updates. 6th edition.
(Walsh PC, Retik AB, Stamey TA, Vaughan ED, Jr. editors). W.B. Saunders, Philadelphia . 1996.
247. Akkus E, Carrier S, Baba K,
Hsu G-L, Padma-Nathan H, Nunes L and Lue TF: Structural alterations in the tunica albuginea of the
penis: Impact of Peyronie's
disease, aging and impotence. Brit
J Urol 79:47-53, 1997.
248. Lue TF and Dahiya R:
Molecular biology of erectile function and dysfunction. Molecular Urology
1:55-64, 1997.
249. Parivar F and Lue TF:
Priapism. In Male Infertility and Sexual Dysfunction. Hellstrom WJG (ed).
Springer-Verlag New York Inc. New York, pp. 401-408, 1997.
250. El-Sakka A and Lue TF: Penile
augmentation: myths and realities. Urol International4:10-12, 1997.
251. Carrier S, Morgan DM, Zvara P, Nunes L,
and Lue TF: Age decreases nitric oxide-containing nerve fibers in the rat
penis. J Urol 157:1088-92, 1997.
252. Lue TF: Physiology of penile
erection and pathophysiology of impotence and priapism. Campbell's Urology 7th
edition. (Walsh PC, Retik AB, Vaughan ED, Jr. & Wein A. editors). W.B. Saunders, Philadelphia. p.
1157-1179, 1997.
253. Lue TF and Broderick G:
Evaluation and nonsurgical management of erectile dysfunction and priapism.
Campbell's Urology 7th edition. (Walsh PC, Retik AB, Vaughan ED, Jr. & Wein
A. editors). W.B. Saunders,
Philadelphia. p. 1181-1214, 1997.
254. El-Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, and Lue, TF: Peyronie's disease is associated with an increase
in transforming growth factor beta protein expression. J Urol 158: 1391-4,
1997.
255. Dahms SE, Piechota HJ,
Nunes L, Dahiya R, Lue, TF, Tanagho EA: Free ureteral replacement in rats:
regeneration of ureteral wall components in the acellular matrix graft. Urology
50:818-825, 1997.
256. El-Sakka, AI, Hassoba,HM, Chui,RM,
Bhatnagar, RS , Dahiya,R and Tom
F. Lue, TF: An animal model of Peyronie's-like condition associated with an
increase of transforming growth factor beta mRNA and protein expression. J
Urol. 158:2284-90 , 1997.
257. El-Sakka and Tom F. Lue, TF: Peyronie's
disease. Current Opinion in Urology 8: 203-209, 1998.
258. Lue, TF: editorial comment on
Peripheral distribution of the human dorsal nerve of the penis. by Yang CC and
Bradley WE. J Urol 159: 1916-7, 1998.
259. Piechota HJ, Dahms SE, Nunes
LS, Dahiya R, Lue TF and Tanagho EA: In vitro functional properties of the rat
Bladder regenerated by the acellular matrix graft. J Urol 159: 1717-1724, 1998.
260. Piechota HJ, Dahms SE, Probst
M, Gleason CA, Nunes LS, , Dahiya R, Lue TF and Tanagho EA: Functional rat
bladder regeneration through xenotransplantation of the bladder acellular
matrix graft. Br. J Urol. 81: 548-559, 1998.
261. El-Sakka, A. I., Selph, C. A., Yen, T. S. B., Dahiya, R., and Lue, T. F.: The effect of surgical trauma on rat
tunica albuginea. J. Urol. 159(5):1700-7, 1998.
262. El-Sakka A. I., Hassan, M.U., Nunes, L, Bhatanagar R.S, Yen T.S.B and Lue T. F.:
Histological and Ultrastructural alterations in an animal model of Peyronie’s
disease. Br. J. Urol. 81: 445-52, 1998.
263. Baskin LS and Lue, TF: The
correction of congenital penile curvature in young men. Br. J. Urol 81:895-899,
1998.
264. Goldstein
I; Lue TF; Padma-Nathan H; Rosen RC; Steers WD; Wicker PA. : Oral sildenafil in
the treatment of erectile dysfunction. Sildenafil Study Group. N Eng J Med 338:1397-404.1998
265. Lue
TF: Local interferon-alpha2b is not an effective treatment in early-stage Peyronie's disease.J Urol 159:1777-8,
1998.
266. Hanson-Divers
C; Jackson SE; Lue TF; Crawford SY; Rosen RC.: Health outcomes variables
important to patients in the treatment of
erectile dysfunction. J Urol 159:1541-7, 1998
267. Borirakchanyavat
S; Aboseif SR; Carroll PR; Tanagho EA; Lue TF.: Continence mechanism of the
isolated female urethra: an anatomical study of the intrapelvic somatic nerves. J Urol 158:822-6,
1997
268. Dahiya
R, Lin A, Bakircioglu ME, Huang ST and Lue TF: mRNA and protein expression of nitric
oxide synthase and adrenoceptor alpha 1 in young and old rat penile tissue.
Brit J 80:300- 6,
1997
269. Borirakchanyavat
S and Lue TF.: Penile surgery. In Recent Advances in Urology (Kirby RS & O'Leary
MP eds) p. 51-60, 1998
270. Lin
AS; Carrier S; Morgan DM; Lue TF.: Effect of simulated birth trauma on the
urinary continence
mechanism in the rat. Urology,
1998 , 52:143-51.
271. Jackson
SE; Lue TF. : Erectile dysfunction: therapy health outcomes. Urology, 1998 , 51:874-82.
272. Dahms SE, Piechota HJ, Dahiya R, Lue TF and Tanagho EA: Composition and
biochemical properties of the bladder acellular matrix graft: comparative
analysis in rat, pig and human. Brit J Urol 1998; 82:411-419.
273. Nitahara KS and Lue TF: Chap 68
Peyronie's disease. In Glenn's Urologic Surgery , 5th edition. (Graham SD ed.)
Lippincott-Raven Publishers. New York, p. 565-9, 1998.
274. Nitahara KS and Lue TF: Chap
69 Priapism. In Glenn's Urology, 5th edition, (Graham SD ed.) Lippincott-Raven
Publishers. New York, p. 571-5, 1998.
275. Jung G-W, Spender EM, Lue,
TF: Growth hormone enhances regeneration of nitric oxide synthase-containing
penile nerves after cavernous neeurotomy in rats. J Urol 160:1899-1904, 1998.
276. Lue
T. F. and El-Sakka A. I.: Venous patch graft for Peyronie’s disease:
part I,
technique. J. Urol. 2047-9, 1998.
277. El-Sakka A. I., Rashwan H. M. and
Lue T. F.: Venous patch graft for Peyronie’s disease: part II, outcome analysis.
J. Urol. 2050-3, 1998.
278. Lue: Comment on penile
arterial revascularization in Atlas of Urologic Surgery, Hinman F, Jr. 2nd
edition, W. B. Saunders Company, Philadelphia, p 197, 1998.
279. El-Sakka A. I., Hassan M. U., Selph
C., Perinchery G., Dahiya R., and Lue T. F.: Effect of cavernous nerve freezing
on protein and gene expression of nitric oxide synthase in the rat penis and
pelvic ganglia. J. Urol. 160: 2245-52, 1998.
280. Ul-Hassan M. , El-Sakka A. I., Yen T.S.B and Lue T. F.: Expression of
TGF-ß1 mRNA and ultrastructural alterations in pharmacologically induced
prolonged penile erection in a canine model. J. Urol. 160:2263-6, 1998.
281. Chang CJ, Huang S-T, Hsu K,
Lin A, Stoller ML and Lue TF: Electroacupuncture decreases c-fos expression in
the spinal cord induced by noxioius stimulation of the rat bladder. J Urol
160:2274-9, 1998.
282.
Deirmenjian JM and Lue, TF: Correction of Peyronie's
curvature using vein grafts and plaque incision. Chap. 83 in Reconstructive and plastic surgery of
the external genitalia -adult and pediatric. Ehrlich RM and Alter GJ (eds) W.B.
Saunders Company. Philadelphia. pp. 495-8. 1998.
283.
Lin C-S, Lau A and Lue TF: Analysis and mapping of
plastin phosphorylation. DNA and Cell Biol 17:1041-6, 1998.
284.
Lin, C.-S., Lau, A., Bakircioglu, M. E., Tu, R., Wu,
F., Week, S., Nunes, L., and Lue, T. F.: Analysis of neuronal nitric oxide
synthase isoform expression and identification of human nNOS-m. Biochem Biophys
Res Commun 253:388-394, 1998.
285.
Jung GW, Spencer EM, Lue TF: Growth hormone enhances
regeneration of nitric oxide synthase-containing penile nerves after cavernous
nerve neurotomy in rats. J Urol. 1998 Nov;160(5):1899-904.
286.
El-Sakka A. I., Hassan M. U., Bakircioglu M. E.,
Pillarisetty R. J., Dahiya R., and Lue T. F.: Possible molecular mechanisms of
cryoablation mediated-impotence in a rat model. Urology 52:1144-1150, 1998.
287.
Kour NW and Lue: Physiology and Pathophysiology of
erection and ejaculation. In Textbook of Genito-Urinary Surgery, ( Whitfield HN, Hendry WF, Kirby RS and
Duckett JW. editors). Blackwell
Scientific Publications Ltd, Oxford, UK. P. 1323-1332, 1998.
288.
Aboseif, SR; Borirakchanyavat, S; Lue, TF; Carroll,
PR. Continence mechanism of the
ileal neobladder in women: a
urodynamics study. World Journal of Urology, 1998, 16(6):400-4.
289.
Carson, CC; Lue, T; Levine, L; Jordan, G; Pryor,
J. Symposium on Peyronie's disease
April 12, 1997. International Journal of Impotence Research, 1998 Jun,
10(2):121-2.
290.
Lin, C.-S., Lau, A., Huynh, T., and Lue, T. F.
Differential regulation of human T- gene in leukocytes and non-leukocytes:
identification of the promoter, enhancer, and CpG island. DNA and Cell Biol
18:27-37, 1999.
291.
Lue TF, El-Sakka A: Peyronie’s disease. in Atlas of
Clinical Urology. Edited by Lue TF and Goldstein M. Current Medicine, Inc.,
Philadelphia, 1999. pp. 8.1-8.8.
292.
Lue T. F. and El-Sakka A. I: Lengthening shortened
penis caused by Peyronie's disease using circular venous grafting and daily
stretching with a vacuum erection device. J. Urol 161:1141-1144, 1999.
293.
Nitahara K and Lue, TF:
Microscopic anatomy of the penis and corpora cavernosa. In : Diagnosis and
Treatment of Male Erectile Dysfunction. (Kirby R, Goldstein I and Carson CC,
III (eds) ISIS Medical Media, Oxford. 1999 p. 31-41.
294.
El-Sakka A. I., Lin, C., S. Chui, R., M. Dahiya, R.
Lue. T. F.:Effect of diabetes on nitric oxide synthase and growth factor gene
and protein expression in an animal model. Int. J. Impotence Research. 11:123-32,
1999.
295.
Dahiya R, Chui R, Perinchery G, Nakajima K, Oh BR and
Lue TF: Differential gene expression of growth factors in young and old rat
penile tissues is associated with erectile dysfunction. Int J Impotence
Research 11:201-206, 1999.
296.
Piechota, HJ; Gleason, CA; Dahms, SE; Dahiya, R;
Nunes, LS; Lue, TF; Tanagho, EA.
Bladder acellular matrix graft: in vivo functional properties of the
regenerated rat bladder. Urological Research, 1999; 27(3):206-13.
297.
El-Sakka, AI; Bakircioglu, ME; Bhatnagar, RS; Yen,
TS; Dahiya, R; Lue, TF. The
effects of colchicine on a Peyronie's-like condition in an animal model.
Journal of Urology, 1999; 161(6):1980-3.
298.
Lue, TF.
Priapism after transurethral alprostadil. Journal of Urology, 1999;
161(2):725-6.
299.
Lue, TF.
Penile prosthetic infection: management by delayed and immediate salvage
techniques. Journal of Urology, 1999 May, 161(5):1727-8.
300.
Lue TF: Future treatment for ED: growth factors and
gene therapy. Int J Impotence Research (Supplement 1) 11: S 56-7, 1999.
301.
Lue TF: Topical and oral agents for erectile
dysfunction. J Formosan Med Assoc. 98:233-41, 1999.
302.
Jung GW, Kwak JY, Yoon S, Jung DG, Yoon JH and Lue
TF: IGF-1 and TGF-b2 have a key role on regeneration of nitric oxide synthase
(NOS)-containing nerves after cavernous neurotomy in rats. Int J Impotence
Research11:247-259, 1999.
303.
Lue, TF.
Surgery for crural venous leakage. Urology, 1999: 54(4):739-41.
304.
El-Sakka A. I., and Lue T. F.: Male erectile
Dysfunction. in Gerhaz E. W., Emberton M., O’Brien T. (eds) Classic papers in
urology, Isis medical media Ltd, Oxford UK. p 249-p271, 1999.
305.
Lin C-S, Lau A, Tu R and Lue TF: Expression of three
isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile
cavernosum. Biochem Biophys Res Commun. 268,628-635, 2000.
306.
Lin C-S, Lau A, Yeh C-C, Chang C-H, and Lue TF:
upregulation of L-plastin gene by testosterone in breast and prostate cancer
cells: identification of three cooperative androgen receptor-binding sequences.
DNA and Cell Biology, 19:1-7, 2000.
307.
Lue TF and Graziottin, TM: Male and female sexual
dysfunction. In Urology Highlight 1999-2000, Julian Shah (ed), Health Press,
Oxford, UK. P. 81-87, 2000.
308. Lue, T.F.:
Male sexual dysfunction.
In Smith's General Urology 15th edition, San Francisco, Lange Medical
Books/McGrew-Hill (Tanagho, E.A. and McAninch, J.W., eds.), 2000, pp. 788-810.
309. Tanagho
EA and Lue, T.F.: Neuropathic
bladder disorders. In
Smith's General Urology 15th edition, , San Francisco, Lange Medical
Books/McGrew-Hill (Tanagho, E.A. and McAninch, J.W., eds.) 2000, pp 498-515.
310. Bakircioglu
ME, Sievert K-D, Lau A, Lin C-S,
and Lue TF: The Effect of
Pregnancy and Delivery on the Function and Ultrastructure of the Rat Bladder
and Urethra. Brit J Urol 85:350-361, 2000
311. Lue
TF and Lee K: Pharmacologic treatment of impotence. Chinese Med J. 113:291-298, 2000.
312. Lue
T, Goldstein I, Traish A:Comparison of oral and intracavernosal vasoactive
agents in penile erection. Int J Impotence Research12:S81-88, 2000.
313. Lue
T, Goldstein I, Traish A: Comparison of oral and intracavernosal vasoactive
agents in penile erection. Int J Impot Res. 2000 Mar;12 Suppl 1:S81-88.
314. Baba
K, Yajima M, Carrier S, Akkus E, Reman J, Nunes L, Lue TF, Iwamoto T: Effect of
testosterone on the number of NADPH diaphorase-stained nerve fibers in the rat
corpus cavernosum and dorsal nerve. Urology. 2000 Sep 1;56(3):533-8.
315. Baba,
K; Yajima, M; Carrier, S; Morgan, DM; Nunes, L; Lue, TF; Iwamoto, T. Delayed testosterone replacement restores nitric oxide
synthase-containing nerve fibres and the erectile response in rat
penis.
Bju International, 2000 May, 85(7):953-8.
316. Goldstein, I., Bancroft, J., Guiliano, F., Heaton, J.P.W., Lewis,
R.W., Lue, T.F., McKenna, K.E., Padma-Nathan, H., Rosen, R., Sachs, B.D.,
Segraves, R.T. and Steers, W.D.: Male Sexual Circuitry. Sci. Am. 283 (2): 70 -
75, 2000.
317. El-Sakka AI, Lue TF:
Medical Management of Impotence, AUA Practical cases in Urology Series XXIII
(2000), Course # 3. Wein AJ, Editor. P. 123-131, 2000.
318. Perinchery G, El-Sakka AI, Angan A, Nakajima K, Dharia A, Tanaka
Y, Lue TF, Dahiya R: Microsatellite alterations and loss of heterozygosity in
Peyronie's disease. J Urol. 2000 Sep;164(3 Pt 1):842-6.
319. Lue TF, Gelbard MK, Gueglio G, Jordan GH, Levine LA,
Moreland R, Pryor J, Ralph D, Yachia D: Peyronie’s disease, in Erectile Dysfunction (2000) Procedings of the First International
Consultation on Erectile Dysfunction co-sponsored by W.H.O. and I.C.E.D. Jardin
A, Wagner G, Khoury S, Giuliano F, Padma-Nathan H, Rosen R, eds. Health
Publication Ltd, Oxford, 2000 p. 437-475.
320. Lue
TF: Erectile dysfunction. N Eng J Med 342:1802-13, 2000.
321. Bakircioglu
, ME, Hsu, K, El-Sakka A, Sievert, K-D, Lin, CS, and Lue, TF: The
Effect of a Chinese Herbal Medicine Mixture on a Rat Model of
Hypercholesterolemic Erectile Dysfunction. J Urol 164: 1798-1801, 2000.
322. Lue,
TF and El-Sakka AI: Erectile
dysfunction. In
Comprehensive Urology, (Weiss, R.M , George, N.J.R. and. O'Reilly, P.H.,, eds.)
London: Mosby , Chap. 40. pp 597-612,2001
323. Liu
X, Lin CS, Spencer EM, Lue TF.: Insulin-like growth factor-I promotes
proliferation and migration of cavernous smooth muscle cells. Biochem Biophys
Res Commun. 2001 Feb 9;280(5):1307-15.
324. Lin
C, Chow S, Lau A, Tu R, Lue TF.: Regulation of human PDE5A2 intronic promoter
by cAMP and cGMP: identification of a critical Sp1-binding site. Biochem
Biophys Res Commun. 2001 Jan 26;280(3):693-9.
325. Lin
CS, Chow S, Lau A, Tu R, Lue TF.: Identification and regulation of human PDE5A
gene promoter. Biochem Biophys Res Commun. 2001 Jan 26;280(3):684-92.
326. Gholami
SS, Lue TF: Peyronie’s disease. Urol Clinics North America 28: 377-390, 2001
327. Sievert K-D, Bakircioglu ME, Tsai T,
Nunes L, Dahms SE and Lue TF: The effect of simulated birth trauma
and/or ovariectomy on rodent continence mechanism. Part I: functional and
structural changes. J Urol. 166:311-317, 2001.
328. Graziottin
TM, Resplande J and Lue TF: Chap. 19 Surgical Treatment of Peyronie’s
disease.pp 321-334, 2001. In Male
sexual function-a guide to clinical management.pp Mulcahy JJ (Ed). Humana Press, Totowa, NJ.
329. Liu
X, Lin C-S, Graziottin T, Resplande J and Lue TF: Vascular endothelial growth
factor promotes proliferation and migration of cavernous smooth muscle cells. J
Urol: 166: 354-360, 2001.
330. Lin
CS, Liu X, Tu R, Chow S, Lue TF.:Age-related
decrease of protein kinase g activation in vascular smooth muscle cells.
Biochem Biophys Res Commun. 2001 Sep 14;287(1):244-8.
331. El-Sakka
A, Yen TS, Lin CS, Lue TF.: Traumatic arteriogenic erectile dysfunction: a rat
model. Int J Impot Res. 2001 Jun;13(3):162-71.
332. Bakircioglu
ME, Sievert KD, Nunes L, Lau A, Lin CS, Lue
TF.: Decreased trabecular smooth muscle and caveolin-1 expression in the
penile tissue of aged rats. J Urol. 2001 Aug;166(2):734-8.
333. Lin
CS, Ho HC, Gholami S, Chen KC, Jad A, Lue
TF.: Gene expression profiling of an arteriogenic impotence model. Biochem
Biophys Res Commun. 2001 Jul 13;285(2):565-9.
334. Bakircioglu
ME, Lin CS, Fan P, Sievert KD, Kan YW, Lue
TF.: The effect of adeno-associated virus mediated brain derived
neurotrophic factor in an animal model of neurogenic impotence. J Urol. 2001
Jun;165(6 Pt 1):2103-9.
335. Graziottin
TM, Resplande J, Gholami SS, Lue TF: Peyronie’s disease. Brzailian J Urol
2001;27:326-340.
336. Lin
CS, Lue TF.: Application of molecular biology to impotence research. Mol Urol.
2001 Autumn;5(3):91-8.Lue TF.: Neurogenic erectile dysfunction. Clin Auton Res.
2001 Oct;11(5):285-94.
337. Lin
CS, Liu X, Tu R, Chow S, Lue TF.: Age-related decrease of protein kinase G
activation in vascular smooth muscle cells. Biochem Biophys Res Commun. 2001
Sep 14;287(1):244-8.
338. Lee
MC, El-Sakka AI, Graziottin TM, Ho HC, Lin CS, Lue TF.: The effect of vascular
endothelial growth factor on a rat model of traumatic arteriogenic erectile
dysfunction. J Urol. 2002 Feb;167(2 Pt 1):761-7.
339. Lin
CS, Chow S, Lau A, Tu R, Lue TF: Human PDE5A gene encodes three PDE5 isoforms
from two alternate promoters. Int J Impot Res. 2002 Feb;14(1):15-24.
340. Lin CS, Lin G, Chen KC, Ho HC, Lue TF:
Vascular Endothelial Growth Factor Induces IP-10 Chemokine Expression. Biochem
Biophys Res Commun. 2002 Mar 22;292(1):79-82.
341. Berger
R, Billups K, Brock G, Broderick GA, Dhabuwala CB, Goldstein I, Hakim LS,
Hellstrom W, Honig S, Levine LA, Lue T, Munarriz R, Montague DK, Mulcahy JJ,
Nehra A, Rogers ZR, Rosen R, Seftel AD, Shabsigh R, Steers W: Report of the
American Foundation for Urologic Disease (AFUD) Thought Leader Panel for
evaluation and treatment of priapism.
342. Gholami
SS, Graziottin TM, Lue TF.:The treatment of erectile dysfunction in the
elderly. Curr Urol Rep. 2001 Feb;2(1):1-2.
343. Graziottin
TM, Resplande J, Nunes L, Rogers R, Gholami S, Lue T.: Long-term survival of
autotransplanted major pelvic ganglion in the corpus cavernosum of adult rats.
J Urol. 2002 Jul;168(1):362-6.
344. Resplande
J, Gholami SS, Graziottin TM, Rogers R, Lin CS, Leng W, Lue TF.: Long-term
effect of ovariectomy and simulated birth trauma on the lower urinary tract of
female rats. J Urol. 2002 Jul;168(1):323-30.
345. Lue TF. Peyronie's disease: an anatomically-based hypothesis and
beyond. Int J Impot Res. 2002 Oct;14(5):411-3.
346. Chang JA, Gholami SS, Lue TF. Surgical management: saphenous vein
grafts. Int J Impot Res. 2002 Oct;14(5):375-8.
347. Latini DM, Penson DF, Colwell HH, Lubeck DP, Mehta SS, Henning JM,
Lue TF. Psychological impact of erectile dysfunction: validation of a new
health related quality of life measure for patients with erectile dysfunction.
J Urol. 2002 Nov;168(5):2086-91.
348. Lin CS, Lin G, Wang Z, Maddah SA, Lue TF. Upregulation of monocyte
chemoattractant protein 1 and effects of transforming growth factor-beta 1 in
Peyronie's disease. Biochem Biophys Res Commun. 2002 Jul 26;295(4):1014-9.
349. Lue
TF: Physiology of penile erection and pathophysiology of erectile dysfunction
and priapism. Campbell's Urology 8th edition. (Walsh PC, Retik AB, Vaughan ED,
Jr. & Wein A. editors). W.B.
Saunders, Philadelphia. p. 1591-1818,
2002.
350. Lue
TF and Broderick G: Evaluation and nonsurgical management of erectile
dysfunction and priapism. Campbell's Urology 8th edition. (Walsh PC, Retik AB,
Vaughan ED, Jr. & Wein A. editors).
W.B. Saunders, Philadelphia. p. 1619-1672, 2002.
351. Lin CS, Lin G, Lue TF. Isolation of two isoforms of
phosphodiesterase 5 from rat penis. Int J Impot Res. 2003 Apr;15(2):129-36.
352. Rogers RS, Gholami S and Lue TF: Erectile Dysfunction after
Treatment. Prostate Cancer (Carroll PR, Grossfeld GD eds.) BC Decker Inc.
London. P. 339-360, 2002.
353. Lue TF. Editorial: male sexual dysfunction-how little do we know?
J Urol. 2003 Jun;169(6):2265.
354. Lin CS, Xin ZC, Lin G, Lue TF. Phosphodiesterases as therapeutic
targets. nUrology. 2003 Apr;61(4):685-91.
355. Penson DF, Latini DM, Lubeck DP, Wallace KL, Henning JM, Lue TF.
Do impotent men with diabetes have more severe erectile dysfunction and worse
quality of life than the general population of impotent patients? Results from
the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED)
database. Diabetes Care. 2003 Apr;26(4):1093-9.
356. Gholami SS, Rogers R, Chang J, Ho HC, Grazziottin T, Lin CS, Lue
TF. The effect of vascular endothelial growth factor and adeno-associated virus
mediated brain derived neurotrophic factor on neurogenic and vasculogenic
erectile dysfunction induced by hyperlipidemia. J Urol. 2003
Apr;169(4):1577-81.
357. Penson DF, Latini DM, Lubeck DP, Wallace K, Henning JM, Lue T. Is
quality of life different for men with erectile dysfunction and prostate cancer
compared to men with erectile dysfunction due to other causes? Results from the
ExCEED data base. J Urol. 2003 Apr;169(4):1458-61.
358. Latini DM, Penson DF, Lubeck DP, Wallace KL, Henning JM, Lue TF.
Longitudinal differences in disease specific quality of life in men with
erectile dysfunction: results from the Exploratory Comprehensive Evaluation of
Erectile Dysfunction study. J Urol. 2003 Apr;169(4):1437-42.
359. Gholami SS, Gonzalez-Cadavid NF, Lin CS, Rajfer J, Lue TF.
Peyronie's disease: a review. J Urol. 2003 Apr;169(4):1234-41.
360. Rogers RS, Graziottin TM, Lin CS, Kan YW, Lue TF. Intracavernosal
vascular endothelial growth factor (VEGF) injection and adeno-associated
virus-mediated VEGF gene therapy prevent and reverse venogenic erectile
dysfunction in rats. Int J Impot Res. 2003 Feb;15(1):26-37.
361. Nehra A, Steers WD, Althof SE, Andersson KE, Burnett AL 2nd,
Costabile RA, Goldstein I, Kloner RA, Lue TF, Morales A, Rosen RC, Shabsigh R,
Siroky MB, King L. Third International Conference on the Management of Erectile
Dysfunction: Linking Pathophysiology and Therapeutic Response. J Urol. 2003
Aug;170(2 Pt 2):S3-5.
362. Lin G, Xin ZC, Lue TF, Lin CS.
Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and
priapism. J Urol. 2003 Aug;170(2 Pt 2):S15-8
363. Hsieh
PS, Bochinski DJ, Lin GT, Nunes L, Lin CS, Lue TF. The effect of vascular endothelial growth factor and
brain-derived neurotrophic factor on cavernosal nerve regeneration in a
nerve-crush rat model. BJU Int. 2003 Sep;92(4):470-5.
364. Xin Z, Liu W, Tian L, Yuan Y, Xin H, Fu J, Lin G, Lin CS, Lue TF. Studies on the testis regression related gene profile in aged
male. Beijing Da Xue Xue Bao. 2003 Aug;35(4):364-8.
365. Montague
DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip
ID; Members of the Erectile Dysfunction Guideline Update Panel; Americal
Urological Association.
American Urological Association guideline on the management of priapism. J
Urol. 2003 Oct;170(4 Pt 1):1318-24.
366. Lin G, Chen KC, Hsieh PS, Yeh CH, Lue TF, Lin CS. Neurotrophic
effects of vascular endothelial growth factor and neurotrophins on cultured
major pelvic ganglia. BJU Int. 2003 Oct;92(6):631-5.
367. Bochinski DJ, Deng DY, Lue TF. The
treatment of priapism--when and how? Int J Impot Res. 2003 Oct;15 Suppl 5:S86-90.
368. Wang Z, Lin G, Lue TF, Lin CS. Wogonin
suppresses cellular proliferation and expression of monocyte chemoattractant
protein 1 in Peyronie's plaque-derived cells. BJU Int. 2003 Nov;92(7):753-7.
369. Shirai M, Yamanaka M, Shiina H, Igawa M, Fujime M, Lue TF, Dahiya
R. Downregulation of androgen, estrogen and progesterone receptor genes and
protein is involved in aging-related erectile dysfunction. Int J Impot Res.
2003 Dec;15(6):391-6.
370. Deng
DY, Lue TF: The 16-dot procedure
for penile plication. Atlas of the Urol Clinics of North America Vol. 2
(1):65-72, 2003.
371. Lin CS, Lue TF.
Growth factor therapy and neuronal nitric oxide synthase. Int J Impot Res. 2004
Jun;16 Suppl 1:S38-9.
372. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue
TF, Nehra A, Sharlip ID; AUA Erectile Dysfunction Guideline Update Panel. AUA guideline on the pharmacologic
management of premature ejaculation.J Urol. 2004 Jul;172(1):290-4.
373. Elliott SP, Gulati M, Pasta DJ, Spitalny GM, Kane CJ, Yee R, Lue
TF. Obstructive lower urinary
tract symptoms correlate with erectile dysfunction.Urology. 2004
Jun;63(6):1148-52.
374. Rahman NU, Carrion RE, Bochinski D, Lue TF. Combined penile plication surgery and insertion of
penile prosthesis for severe penile curvature and erectile dysfunction. J Urol.
2004 Jun;171(6 Pt 1):2346-9.
375. Moyad MA, Barada JH, Lue TF, Mulhall JP, Goldstein I, Fawzy A;
Sexual Medicine Society Nutraceutical Committee. Prevention and treatment of
erectile dysfunction using lifestyle changes and dietary supplements: what works
and what is worthless, part I. Urol Clin North Am. 2004 May;31(2):249-57.
376. Moyad MA, Barada JH, Lue TF, Mulhall JP, Goldstein I, Fawzy A;
Sexual Medicine Society Nutraceutical Committee. Prevention and treatment of
erectile dysfunction using lifestyle changes and dietary supplements: what
works and what is worthless, part II. Urol Clin North Am. 2004
May;31(2):259-73.
377. Lin G, Chow S, Lin J, Wang G, Lue TF, Lin CS. Effect of cell
passage and density on protein kinase G expression and activation in vascular
smooth muscle cells. J Cell Biochem. 2004 May 1;92(1):104-12.
378. Bochinski D, Hsieh PS, Nunes L, Lin GT, Lin CS, Spencer EM, Lue
TF. Effect of insulin-like growth factor-1 and insulin-like growth factor
binding protein-3 complex in cavernous nerve cryoablation. Int J Impot Res.
2004 Feb 19.
379. Bochinski D, Lin GT, Nunes L, Carrion R, Rahman N, Lin CS, Lue TF.
The effect of neural embryonic stem cell therapy in a rat model of cavernosal
nerve injury. BJU Int. 2004 Oct;94(6):904-9.
380. Sievert KD, Bakircioglu ME, Tsai T, Nunes L, Lue TF. The effect of labor and/or
ovariectomy on rodent continence mechanism-The neuronal changes. World J Urol.
2004 Sep 9.
381. El-Sakka AI, Lue TF.Physiology of penile erection.
ScientificWorldJournal. 2004 Jun 07;4 Suppl 1:128-34.
382. Lue
TF, Giuliano F, Montorsi F, Rosen RC et al: Summary of the Recommendations on
Sexual Dysfunctions in Men. J Sexual Medicine 1:6-23, 2004.
Books:
Educational
Material:
Lue, T.F.
and Donatucci, C.F : Diagnosis and Treatment of Impotence. Health and Science
Network, Video Program#S5418, March, 1991.
El-Sakka
AI, Lue, TF: Meidcal management of impotence . Practical cases in Urology
series XXIII (2000) course #3. Wein AJ (Editor). American Urological
Association.
Editorial
comments for Urological Survey
Section of Journal of Urology
5-10
comments on current urological literature for the Journal every 3 months,
1/89-7/99